Skip to main content
Translational Andrology and Urology logoLink to Translational Andrology and Urology
. 2020 Apr;9(2):153–165. doi: 10.21037/tau.2020.02.24

Temporal trends of bladder cancer incidence and mortality from 1990 to 2016 and projections to 2030

Qiliang Cai 1,2,#, Yegang Chen 1,#, Shuhui Xin 3, Dingrong Zhang 1, Jiancheng Pan 1, Zunke Xie 1, Chenjie Xu 2, Shu Li 2, Xinyu Zhang 2, Ying Gao 4, Jie Hou 5, Xuemei Guo 6, Xiaodong Zhou 1, Baoshuai Zhang 7, Fei Ma 8, Wei Zhang 1, Guiting Lin 9, Zhongcheng Xin 1,10, Yuanjie Niu 1,, Yaogang Wang 2,
PMCID: PMC7215039  PMID: 32420122

Abstract

Background

Bladder cancer is a leading cause of cancer-related deaths all over the world. Epidemiological studies of bladder cancer are therefore crucial for policy making. This study was carried out to describe the characteristics of changes in the incidence and mortality of bladder cancer from 1990 to 2016 by age group, gender, geographical region, and sociodemographic index (SDI) and to simultaneously project future trends up to 2030.

Methods

Incidence and mortality trends in bladder cancer from 1990 to 2016 were described based on data and methodologies from the Global Burden of Disease (GBD) Study. The data also allowed the future trends of bladder cancer incidence and mortality to be predicted by ARIMA model. Trends were analyzed by age group, gender, and SDI. Projections to 2030 were sub-analyzed by SDI countries. R software (x64 version 3.5.1), SAS (version 9.3), and SPSS (version 22.0) were used throughout the process.

Results

Globally, in 2016, there were 437,442 [95% uncertainty interval (UI), 426,709–447,912] new bladder cancer cases and 186,199 (95% UI, 180,453–191,686) bladder cancer-associated deaths. Between 1990 and 2016, changes in the age-standardized incidence rate (ASIR) of bladder cancer decreased by 5.91% from 7.11 (95% UI, 6.93–7.27) in 1990 to 6.69 (95% UI, 6.52–6.85) in 2016. The age-standardized death rate (ASDR) decreased from 3.58 (95% UI, 3.49–3.68) to 2.94 (95% UI, 2.85–3.03) over the same period of time. In future, the greatest occurrence of bladder cancer will be in high SDI countries, followed by high-middle SDI countries. Moreover, bladder cancer incidence rates may increase substantially in middle SDI countries, while the incidence rates will remain relatively stable for men and women in other SDI countries. From 2017 to 2030, bladder cancer deaths will continue to increase in low SDI countries, while deaths in other SDI countries will continue to decrease.

Conclusions

There was a regional difference in the incidence and mortality trends of bladder cancer between 1990 and 2016. Overall, the situation is not optimistic. From 2017 to 2030, the incidence of bladder cancer will continue to rise, especially in high and high-middle SDI countries, where decision-makers should propose appropriate policies on the screening and prevention of bladder cancer.

Keywords: Bladder cancer, incidence, mortality, over-time trends, projections

Introduction

Bladder cancer is one of the most common types of cancer and is a prominent cause of cancer-related deaths all over the world (1). Bladder cancer is more likely to affect older people and men (2), and along with the growing and ageing global population, the number of cancer-related deaths has dramatically increased, which in part can be attributed to its recurrence rate of up to 75% (1,3).

Due to international differences in the incidence and mortality of bladder cancer, the burden of bladder cancer is becoming more noticeable (4,5). Necessary data to inform health policies with respect to urologic cancer at a global level, including cancer control and implementation plans, are not widely available. This study therefore aims to describe the global burden of urologic cancer from 1990 to 2016 according to age, sex, region, and sociodemographic index (SDI) (a summary indicator of income per capita, educational attainment, and fertility), and then forecast worldwide bladder cancer incidence and mortality rates for the next 15 years. Understanding these factors is critical for providing detailed information on bladder cancer etiologies and their trends over time, without which targeted prevention strategies are impossible to design and evaluate, and for promoting strategic investments into research and clinical resources.

Methods

Methodology and research processes for the Global Burden of Disease (GBD) Study have been reported previously in many publications (6-11). Herein, we present methods for the incidence, mortality, trends, and 15-year prediction of bladder cancer from 1990 to 2030 based on the data collected from the GBD study. Our study complies with the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER) and the detailed methodology also complies with the GATHER guidelines (12). Tables, which can be found in the Supplementary materials (Tables S1-S9), record the estimation steps and other detailed information about the methodology (7,13-15). The International Classification of Diseases 10 (ICD-10) codes corresponding to bladder cancer incidence and mortality are C67-C67.9, Z12.6-Z12.79, Z80.52, Z85.51 and C67-C67.9, D09.0, D30.3, D41.4-D41.8, D49.4, respectively.

Table S1. Sources for cancer incidence and mortality-to-incidence (MI) ratio data by country, year, and registry.

Location Registry   Years available from registry     Years used for incidence Years available for MI ratio Years used for MI ratio
Algeria Algiers   1993–1997 5 1993–1997 0
Algeria Batna   2000–2006 7 2000–2006 0
Algeria Oran   2005–2006 2 2005–2006 0
Algeria Setif   1986–2007     18 1986–2007 0
Antilles except Aruba Antilles except Aruba   1973–1982 0 NA NA
Argentina Bahia Blanca   1993–2007     15 1993–2007 0
Argentina Concordia   1990–1997     10 1990–1997 0
Argentina Cordoba   2003–2007 4 2004–2007 0
Argentina Mendoza   2003–2007 5 2003–2007 0
Argentina Tierra del Fuego   2003–2007 5 2003–2007 0
Australia Capital Territory   1978–2007     25 1983–2007 0
Australia National Registry   1982–2007     26 1968–2007 26
Australia New South Wales   1973–2007     25 1983–2007 0
Australia Northern Territory   1993–2007     10 1998–2007 0
Australia Queensland   1982–2007     15 1993–2007 0
Australia South Australia   1977–2007     31 1977–2007 0
Australia Tasmania   1978–2007     30 1978–2007 0
Australia Victoria   1982–2007     25 1983–2007 0
Australia Western Australia   1982–2007     25 1983–2007 0
Austria National Registry   1983–2010     31 1983–2010 7
Austria Salzburg   NA     NA 1999–2006 0
Austria Tyrol   1988–2007 0 1988–2007 0
Austria Vorarlberg   1993–2007 0 1993–2007 0
Bahrain National Registry   1998–2007     10 1998–2007 0
Belarus National Registry   1983–2007     25 1983–2007 0
Belgium Antwerp   1998–2002 5 1998–2002 0
Belgium Flanders   1998–2001 4 1998–2001 0
Belgium Flanders except Limburg   1997–1998 2 1997–1998 0
Belgium Limburg   1997–1998 2 1997–1998 0
Belgium National Registry   2003–2010 7 2003–2010 0
Bermuda Bermuda   1983–1987 5 1983–1987 0
Brazil Aracaju   1996–2012 17 1996–2012 0
Brazil Barretos   2008–2013 6 2008–2013 0
Brazil Belem   1989–2009 17 1989–2009 0
Brazil Belo Horizonte   2000–2008 9 2000–2008 0
Brazil Brasilia   1998–2001 4 1998–2001 0
Brazil Campinas   1991–2005 15 1991–2005 0
Brazil Campo Grande   2000–2009 6 2000–2009 0
Brazil Cuiaba   2000–2007 8 2000–2007 0
Brazil Curitiba   1998–2010 13 1998–2010 0
Brazil Distrito Federal   1999–2002 4 1999–2002 0
Brazil Espirito Santo   1997–2012 16 1997–2012 0
Brazil Florianopolis   2008–2012 5 2008–2012 0
Brazil Fortaleza   1978–2006 25 1978–2006 0
Brazil Goiania   1988–2009 22 1988–2009 0
Brazil Jahu   1996–2013 18 1996–2013 0
Brazil Joao Pessoa   1999–2010 12 1999–2010 0
Brazil Manaus   1999–2006 8 1999–2006 0
Brazil MatoGrosso Interior   2001–2005 5 2001–2005 0
Brazil Natal   1999–2005 7 1999–2005 0
Brazil Palmas   2000–2012 13 2000–2012 0
Brazil Pocos de Caldas   2007–2011 5 2007–2011 0
Brazil Porto Alegre   1979–2006 22 1979–2006 0
Brazil Recife   1968–2010 17 1968–2010 0
Brazil Roraima   2003–2010 8 2003–2010 0
Brazil Salvador   1996–2005 10 1996–2005 0
Brazil Santos   2008–2009 2 2008–2009 0
Brazil Sao Paulo   1969–2011 17 1969–2011 0
Brazil Teresina   2000–2006 7 2000–2006 0
Bulgaria National Registry   1993–2010 12 1993–2010 12
Canada Alberta   1960–2007 32 1960–2007 0
Canada British Columbia   1969–2007 32 1969–2007 0
Canada Manitoba   1958–2007 32 1958–2007 0
Canada Maritime   1969–1987 9 1969–1987 0
Canada National Registry   1978–2007 30 1978–2007 0
Canada New Brunswick   1962–2007 25 1962–2007 0
Canada Newfoundland   1969–2002 26 1969–2002 0
Canada Newfoundland and Labrador   1960–2007 9 1960–2007 0
Canada Northwest Territories   1983–2007 0 1983–2007 0
Canada Northwest Territories and Yukon   1973–1987 5 1973–1987 0
Canada Nova Scotia   1978–2007 20 1978–2007 0
Canada Ontario   1969–2007 23 1969–2007 0
Canada Prince Edward Island   1978–2007 16 1978–2007 0
Canada Quebec   1963–2007 13 1963–2007 0
Canada Saskatchewan   1960–2007 34 1960–2007 0
Canada Yukon   1983–2007 0 1983–2007 0
Chile Antofagasta   2003–2007 0 2003–2007 0
Chile Bio Bio   2003–2007 5 2003–2007 0
Chile Los Rios   2003–2007 5 2003–2007 0
Chile National Registry   1959–1961 0 1959–1961 0
Chile Valdivia   1998–2007 10 1998–2007 0
China Anshan   1998–2011 11 1998–2011 13
China Baoding   2009–2011 2 2009–2011 2
China Beijing   1990–2011 22 1990–2011 21
China Beijing Rural Areas   2011 0 2011 0
China Beiliu   2011 1 2011 1
China Bengbu   2011 1 2011 1
China Benxi   2003–2011 8 2003–2011 8
China Bijiang District, Tongren   2011 1 2011 1
China Bincheng District, Binzhou   2011 1 2011 1
China Binghai   2011 1 2011 1
China Boli   2011 1 2011 1
China Cangwu   2011 1 2011 1
China Cangzhou   2011 1 2011 1
China Changfeng   2011 1 2011 1
China Changle   1990–2011 21 1990–2011 21
China Changning   2011 1 2011 1
China Changzhou   2011 1 2011 1
China Chifeng   2009–2011 2 2009–2011 2
China Chuzhou District, Huai’an   2004–2007 3 2004–2007 0
China Ci County   1990–2009 23 1990–2009 12
China Cili   2011 1 2011 1
China Cixi   2011 1 2011 1
China Cixian   2011 1 2011 1
China Daan   2011 1 2011 1
China Dafeng   2003–2011 6 2003–2011 8
China Dalian City   1998–2011 12 1998–2011 13
China Dancheng   2011 1 2011 1
China Dandong   2008–2011 3 2008–2011 3
China Daoli District, Harbin City   2005–2011 5 2005–2011 6
China Dawukou   2011 1 2011 1
China Dazhu   2011 1 2011 1
China Decheng District, Dezhou   2011 1 2011 1
China Dehui   2009–2011 2 2009–2011 2
China Dingan   2011 1 2011 1
China Donggang   2009–2011 2 2009–2011 2
China Donghai County   2004–2011 3 2004–2011 2
China Dunhuang   2011 1 2011 1
China Faku   2011 1 2011 1
China Feicheng   1998–2011 13 1998–2011 13
China Feidong   2011 1 2011 1
China Feixi County   2009–2011 2 2009–2011 2
China Fusui County   1990–2011 14 1990–2011 8
China Fuyuan   2011 1 2011 1
China Ganyu   2004–2011 2 2004–2011 1
China Ganzhou District, Zhangye   2011 1 2011 1
China Gaomi   2011 1 2011 1
China Gaotang   2011 1 2011 1
China Gejiu   2004–2011 3 2004–2011 2
China Gongan   2011 1 2011 1
China Guangrao   2011 1 2011 1
China Guangzhou City   2000–2011 9 2000–2011 11
China Guannan   2011 1 2011 1
China Guanyun County   2004–2011 3 2004–2011 3
China Guilin   2011 1 2011 1
China Guyuan   2011 1 2011 1
China Hai’an County   2009–2011 2 2009–2011 2
China Haimen   2003–2011 7 2003–2011 8
China Hainan   2011 1 2011 1
China Haining   1998–2011 11 1998–2011 13
China Hangzhou City   2000–2011 9 2000–2011 11
China Hanjiang District, Putian   2011 1 2011 1
China Hefei   2011 1 2011 1
China Hengdong County   2009–2011 2 2009–2011 2
China Hepu   2011 1 2011 1
China Hetian   2011 1 2011 1
China Hong Kong Special Administrative Region of China   1974–2013 43 1974–2013 8
China Hongta District, Yuxi   2011 1 2011 1
China Hongtong   2011 1 2011 1
China Hongze   2011 1 2011 1
China Huai’an District, Huai’an   1998–2009 12 1998–2009 12
China Huaiyin District, Huai’an   2009–2011 2 2009–2011 2
China Huangdao District, Qingdao   2011 1 2011 1
China Huian   2011 1 2011 1
China Huichuan District, Zunyi   2011 1 2011 1
China Huinong   2011 1 2011 1
China Huixian   2011 1 2011 1
China Huzhu   2011 1 2011 1
China Jiangmen   2011 1 2011 1
China Jianhu County   2003–2011 6 2003–2011 8
China Jianou   2011 1 2011 1
China Jianping   2011 1 2011 1
China Jiashan County   1990–2011 22 1990–2011 21
China Jiaxing   2000–2011 10 2000–2011 11
China Jilin   2011 1 2011 1
China Jinan   2011 1 2011 1
China Jingan   2011 1 2011 1
China Jingtai County   2009–2011 2 2009–2011 2
China Jingxian   2011 1 2011 1
China Jingyang   2011 1 2011 1
China Jinhu County   2007–2011 3 2007–2011 4
China Jintan District   2003–2011 6 2003–2011 7
China Jinzhai   2011 1 2011 1
China Jiulongpo District, Chongqing   2004–2011 3 2004–2011 4
China Jiyuan   2011 1 2011 1
China Junan   2011 1 2011 1
China Kaihua   2011 1 2011 1
China Kailu   2011 1 2011 1
China Kaiyang   2011 1 2011 1
China Kangping   2011 1 2011 1
China Kunes County   2009 1 2009 1
China Lanping   2011 1 2011 1
China Lanzhou   2011 1 2011 1
China Leishan   2011 1 2011 1
China Leshan   2011 1 2011 1
China Lhasa   2011 1 2011 1
China Liangzhou District   2008–2011 3 2008–2011 3
China Lianhu District, Xi’an   2011 1 2011 1
China Lianshui   2011 1 2011 1
China Lianyungang   2004–2011 4 2004–2011 4
China Lingbi   2011 1 2011 1
China Linhe District, Bayannaoer   2011 1 2011 1
China Linqu County   1998–2011 11 1998–2011 13
China Lintan   2011 1 2011 1
China Linxian   2011 1 2011 1
China Linzhou   1990–2011 19 1990–2011 21
China Liuzhou   2009–2011 2 2009–2011 2
China Liyang   2011 1 2011 1
China Longnan   2011 1 2011 1
China Longquanyi District, Chengdu   2011 1 2011 1
China Lujiang   2011 1 2011 1
China Luoshan   2011 1 2011 1
China Luoyang   2011 1 2011 1
China Lushan   2011 1 2011 1
China Ma’anshan   2003–2011 6 2003–2011 8
China Macao Special Administrative Region of China   2003–2007 5 2003–2007 0
China Macheng   2011 1 2011 1
China Maiji District, Tianshui   2011 1 2011 1
China Mayang   2011 1 2011 1
China Meixian   2011 1 2011 1
China Minhe   2011 1 2011 1
China Naidong   2011 1 2011 1
China Nangang District, Harbin City   1992–2011 20 1992–2011 14
China Nantong   2011 1 2011 1
China Neixiang   2011 1 2011 1
China Ningyang   2011 1 2011 1
China Nongqishi   2011 1 2011 1
China Pengzhou   2011 1 2011 1
China Pingluo   2011 1 2011 1
China Qianxi County   2009–2011 2 2009–2011 2
China Qidong County   1983–2011 35 1983–2011 21
China Qingdao   2011 1 2011 1
China Qinghe   2011 1 2011 1
China Qingpu   2011 1 2011 1
China Qingyang District, Chengdu   2009–2011 2 2009–2011 2
China Qinhuangdao   2011 1 2011 1
China Qionghai   2011 1 2011 1
China Renhe District, Panzhihua   2011 1 2011 1
China Rushan   2011 1 2011 1
China Sanmenxia   2011 1 2011 1
China Sanya   2011 1 2011 1
China Shangdong   1993–1997 0 NA NA
China Shanggao   2011 1 2011 1
China Shanghai   1975–2011 31 1975–2011 21
China Shangyu   2009–2011 2 2009–2011 2
China Shangzhi   2009–2011 2 2009–2011 2
China Shangzhou District, Shangluo   2011 1 2011 1
China Shapingba District, Chongqing   2011 1 2011 1
China Shenqiu   2011 1 2011 1
China Shenyang City   2003–2011 7 2003–2011 8
China Shenzen City   2004–2011 2 2004–2011 1
China Shexian County   2003–2011 8 2003–2011 8
China Sheyang County   2008–2011 3 2008–2011 3
China Shifeng District, Zhuzhou   2011 1 2011 1
China Shihezi   2011 1 2011 1
China Shouxian   2011 1 2011 1
China Shouyang   2011 1 2011 1
China Sihui   1998–2011 11 1998–2011 13
China Suzhou   2006–2011 4 2006–2011 5
China Taixing   2004–2011 4 2004–2011 6
China Tengchong   2011 1 2011 1
China Tengzhou   2011 1 2011 1
China Tianchang   2011 1 2011 1
China Tianjin   1981–2011 22 1981–2011 16
China Tianjin Rural Areas   2011 0 2011 0
China Tianshan District, Urumqi   2011 1 2011 1
China Tong’an District, Xiamen   2011 1 2011 1
China Tongguan   2011 1 2011 1
China Tonghua   2011 1 2011 1
China Tongling   2008–2011 3 2008–2011 3
China Wanzhouqu District, Chongqing   2011 1 2011 1
China Wenshang County   2009–2011 2 2009–2011 2
China Wuan   2011 1 2011 1
China Wufeng   2011 1 2011 1
China Wuhan City   1990–2011 22 1990–2011 18
China Wuhu   2011 1 2011 1
China Wuning   2011 1 2011 1
China Wuwei   2004 1 2004 0
China Wuxi   2006–2011 2 2006–2011 2
China Xiamen City   2009–2011 2 2009–2011 2
China Xiang’an District, Xiamen   2011 1 2011 1
China Xiangfang District, Harbin   2011 1 2011 1
China Xianju County   2009–2011 2 2009–2011 2
China Xilinhaote   2011 1 2011 1
China Xinghualing District, Taiyuan   2011 1 2011 1
China Xining   2009–2011 2 2009–2011 2
China Xinyuan   2011 1 2011 1
China Xinzhou District, Shangrao   2011 1 2011 1
China Xiping County   2009–2011 2 2009–2011 2
China Xuanwei   2011 1 2011 1
China Xuyi County   2009–2011 2 2009–2011 2
China Xuzhou   2011 1 2011 1
China Yakeshi   2011 1 2011 1
China Yancheng   2011 1 2011 1
China Yancheng District, Luohe   2011 1 2011 1
China Yangcheng County   2003–2011 6 2003–2011 8
China Yangquan   2009–2011 2 2009–2011 2
China Yangshan   2011 1 2011 1
China Yangzhong   1998–2011 12 1998–2011 13
China Yanji   2009–2011 2 2009–2011 2
China Yanshi   2009–2011 2 2009–2011 2
China Yantai   2011 1 2011 1
China Yanting County   1998–2011 10 1998–2011 13
China Yinchuan   2011 1 2011 1
China Yingdong District, Fuyang   2011 1 2011 1
China Yingshan   2011 1 2011 1
China Yiyuan   2011 1 2011 1
China Yongding   2011 1 2011 1
China Yongqiao District, Suzhou   2011 1 2011 1
China Yuanhui District, Luohe   2011 1 2011 1
China Yuanqu   2011 1 2011 1
China Yucheng   2011 1 2011 1
China Yuci District, Jinzhong   2011 1 2011 1
China Yueyanglou   2011 1 2011 1
China Yunmeng County   2009–2011 2 2009–2011 2
China Yuzhong District, Chongqing   2011 1 2011 1
China Yuzhou   2011 1 2011 1
China Zanhuang   2011 1 2011 1
China Zhanggong District   2009 1 2009 1
China Zhanggong District, Ganzhou   2011 1 2011 1
China Zhangqiu   2011 1 2011 1
China Zhaoling District, Luohe   2011 1 2011 1
China Zhaoyuan   2011 1 2011 1
China Zhongshan   1998–2011 12 1998–2011 13
China Zhongshan County   2004–2007 3 2004–2007 0
China Zhongwei   2011 1 2011 1
China Zhongxiang   2011 1 2011 1
China Zhuanghe   2009–2011 2 2009–2011 2
China Zhuhai   2011 1 2011 1
China Ziliujing District   2009 1 2009 1
China Ziliujing District, Zigong   2011 1 2011 1
China Zixing   2011 1 2011 1
China Zoucheng   2011 1 2011 1
Colombia Bucaramanga   2003–2007 5 2003–2007 0
Colombia Cali   1962–2007 40 1962–2007 0
Colombia Manizales   2003–2007 5 2003–2007 0
Colombia National Registry   2003–2010 0 2003–2010 0
Colombia Pasto   2003–2007 5 2003–2007 0
Costa Rica National Registry   1980–2011 33 1980–2013 0
Cote d’Ivoire National Registry   1995–1997 3 1995–1997 0
Croatia National Registry   1988–2010 23 1988–2010 8
Cuba National Registry   1968–1987 11 1968–1986 0
Cuba Villa Clara   1995–2007 7 1995–2007 0
Cyprus National Registry   1998–2007 9 1998–2007 4
Czech Republic National Registry   1983–2010 27 1983–2010 5
Denmark National Registry   1953–2014 50 1953–2014 35
Ecuador Cuenca   2003–2007 5 2003–2007 0
Ecuador Quito   1985–2007 25 1985–2007 0
Egypt Aswan   2008 1 2008 0
Egypt Damietta   2009 1 2009 0
Egypt Gharbiah   1999–2007 9 1999–2007 0
Egypt Minia   2009 1 2009 0
Estonia National Registry   1968–2011 44 1968–2009 5
Fiji National Registry   1998–2010 13 1998–2010 11
Finland National Registry   1953–2014 50 1953–2014 35
France Bas Rhin   1975–2007 33 1975–2007 0
France Calvados   1978–2007 30 1978–2007 0
France Calvados Digestive   1978–2009 6 1978–2009 0
France Cote d’Or   1980–2009 30 1980–2009 0
France Doubs   1977–2009 36 1977–2009 0
France Finistere Digestive   1984–2009 26 1984–2009 0
France Haut Rhin   1988–2009 21 1988–2009 0
France Herault   1987–2009 26 1987–2009 0
France Isere   1979–2009 30 1979–2009 0
France Loire Atlantique   1991–2009 18 1991–2009 0
France Manche   1994–2009 19 1994–2009 0
France Nord   2005–2009 3 2005–2009 0
France Normandy   2002–2009 8 2002–2009 0
France Somme   1982–2009 27 1982–2009 0
France Tarn   1982–2009 27 1982–2009 0
France Vendee   1998–2007 10 1998–2007 0
French Polynesia French Polynesia   1988–2002 0 NA NA
Germany Bavaria   2002–2007 0 2002–2007 0
Germany Berlin   1998–2007 2 1998–2007 0
Germany Brandenburg   1998–2007 2 1998–2007 0
Germany Bremen   2000–2008 0 2000–2008 0
Germany Eastern States (former GDR)   1964–1989 22 1964–1989 0
Germany Free State of Saxony   1998–2007 2 1998–2007 0
Germany Hamburg   1969–2009 16 1969–2010 2
Germany Lower Saxony   2003–2007 0 2003–2007 0
Germany Mecklenburg   1998–2007 2 1998–2007 0
Germany Mecklenburg–West Pomerania   1998–2007 0 1998–2007 0
Germany Munich   1998–2007 0 1998–2007 0
Germany National Registry   2000–2010 11 2000–2010 11
Germany North Rhine Westphalia   1998–2007 2 1994–2007 2
Germany Rhineland Palatinate   2000–2007 0 2000–2007 0
Germany Saarland   1968–2007 30 1968–2007 30
Germany Saxony–Anhalt   1998–2007 2 1998–2007 0
Germany Schleswig Holstein   1998–2007 2 1998–2007 2
Germany Thuringen   1998–2007 2 1998–2007 0
Germany Westphalia   1998–2007 0 1998–2007 0
Greece National Registry   1990–1991 0 1990–1991 0
Greenland Greenland   1980–2014 35 1980–2014 32
Grenada St. George’s Central Hospital   1996–2000 5 1996–2000 0
Guinea Conakry   1992–1995 4 1992–1995 0
Hungary County Szabolcs-Szatmar   1962–1987 18 1962–1987 0
Hungary County Vas   1962–1987 20 1962–1987 0
Hungary Miskolc   1962–1966 0 1962–1966 0
Hungary National Registry   2001–2011 11 2001–2011 0
Iceland National Registry   1955–2014 50 1955–2014 35
India Ahmedabad   1983–2005 12 NA NA
India Ahmedabad Rural   2006–2010 5 NA NA
India Ahmedabad Urban   2006–2013 7 NA NA
India Aizawl   2005–2014 5 NA NA
India Aurangabad   2005–2014 9 NA NA
India Bangalore   1982–2012 24 NA NA
India Barshi Expanded   2009–2012 2 NA NA
India Barshi Rural   1988–2014 20 NA NA
India Bhopal   2004–2013 11 NA NA
India Cachar   2007–2014 7 NA NA
India Chandigarh Union Territory   2013 1 NA NA
India Chennai   1982–2013 34 NA NA
India Delhi   1993–2012 21 NA NA
India Dibrugarh   2005–2014 11 NA NA
India DindigulAmbilikkai   2003–2013 7 NA NA
India Imphal   2005–2014 5 NA NA
India Kamrup Urban   2005–2014 11 NA NA
India Karunagappally   1991–2007 17 NA NA
India Kolkata   2005–2012 6 NA NA
India Kollam   2006–2014 8 NA NA
India Manipur   2006–2010 5 NA NA
India Manipur ExclImphal West   2009–2014 5 NA NA
India Mansa District   2013 1 NA NA
India Meghalaya   2010–2014 5 NA NA
India Mizoram   2003–2010 10 NA NA
India Mizoram ExclAizawl   2005–2014 5 NA NA
India Mumbai   1964–2012 50 NA NA
India Nagaland   2010–2014 4 NA NA
India Nagpur   1980–2013 20 NA NA
India NaharlagunExclPapum Pare   2012–2014 3 NA NA
India Papum Pare   2012–2014 3 NA NA
India Pasighat   2012–2014 3 NA NA
India Patiala District   2012–2014 3 NA NA
India Pune   1973–2013 32 NA NA
India S.A.S Nagar District   2013 1 NA NA
India Sangrur District   2013 1 NA NA
India Sikkim   2003–2014 14 NA NA
India Silchar   2005–2006 2 NA NA
India Tamil Nadu   2012–2013 2 NA NA
India Tripura   2010–2014 4 NA NA
India Trivandrum   1991–2014 21 NA NA
India Wardha   2010–2014 5 NA NA
Iran Ardabil   1985–2008 8 1985–2008 0
Iran Golestan   1996–2007 8 1996–2007 0
Iran National Registry   2003–2007 8 2003–2007 0
Iraq National Registry   2007–2011 3 2007–2011 0
Ireland National Registry   1994–2010 16 1994–2010 0
Ireland Southern Ireland   1980–1992 12 1980–1992 0
Israel National Registry   1960–2010 13 1960–2010 0
Italy Alto Adige   2003–2006 4 2003–2006 0
Italy Biella   1995–2007 13 1995–2007 0
Italy Brescia   1999–2007 7 1999–2006 0
Italy Catania and Messina   2003–2005 3 2003–2005 0
Italy Catanzaro   2003–2007 5 2003–2007 0
Italy Como   2003–2007 5 2003–2007 0
Italy Ferrara   1991–2007 17 1991–2007 0
Italy Florence   1985–2002 18 1985–2002 0
Italy Florence and Prato   1985–2007 21 1985–2005 0
Italy Friuli Venezia Giulia   2003–2007 5 2003–2007 0
Italy Genoa   1986–2007 18 1986–2006 0
Italy Latina   1983–2007 12 1983–2007 0
Italy Lecco   2003–2007 5 2003–2007 0
Italy Macerata   1991–2000 10 1991–2000 0
Italy Mantua   2003–2007 3 2003–2005 0
Italy Milan   1999–2007 8 1999–2006 0
Italy Modena   1988–2007 23 1988–2007 0
Italy Naples   1998–2007 10 1998–2007 0
Italy National Registry   2006–2009 4 2006–2009 4
Italy North East Italy   1995–2002 8 1995–2002 0
Italy Nuoro   2003–2007 5 2003–2007 0
Italy Palermo   2003–2007 4 2003–2006 0
Italy Parma   1978–2007 30 1978–2007 0
Italy Ragusa   1978–2007 31 1981–2007 0
Italy Reggio Emilia   1998–2007 10 1998–2007 0
Italy Romanga   1985–2007 22 1986–2007 0
Italy Salerno   1998–2007 9 1998–2007 0
Italy Sassari   1993–2007 15 1993–2007 0
Italy Sondrio   1998–2007 14 1998–2007 0
Italy South Lombard   2003–2005 3 2003–2005 0
Italy South Tyrol   2003–2007 0 NA NA
Italy Syracuse   1999–2007 9 1999–2007 0
Italy Torino   1984–2007 23 1985–2007 0
Italy Trapani   2003–2006 4 2003–2006 0
Italy Trento   2003–2006 4 2003–2006 0
Italy Trieste   1983–1992 6 1984–1992 0
Italy Umbria   1994–2007 13 1994–2007 1
Italy Varese   1976–2007 32 1976–2007 0
Italy Veneto   1988–2007 17 1988–2006 0
Jamaica National Registry   1958–2007 25 1958–2007 0
Japan Aichi   1998–2007 11 1998–2007 1
Japan Fukui   1998–2007 10 1998–2007 0
Japan Fukuoka   1974–1975 2 1974–1975 0
Japan Hiroshima   1978–2007 28 1978–2007 0
Japan Miyagi   1959–2007 35 1959–2007 0
Japan Nagasaki   1973–2007 35 1973–2007 0
Japan National Registry   1975–2010 36 1958–2013 36
Japan Niigata   2003–2007 5 2003–2007 0
Japan Okayama   1966–1969 0 1966–1969 0
Japan Osaka   1963–2007 38 1963–2007 0
Japan Saga   1984–2007 18 1984–2007 0
Japan Yamagata   1983–2002 23 1983–2002 0
Jordan National Registry   2001–2008 8 2001–2008 0
Kenya Nairobi   2000–2002 3 2000–2002 0
Kuwait National Registry   1979–2007 28 1979–2007 0
Kyrgyzstan National Registry   1986–1987 2 1986–1987 0
La Martinique La Martinique   1981–2002 0 NA NA
La Reunion La Reunion   1988–1994 0 NA NA
Latvia National Registry   1983–2007 24 1983–2007 5
Lebanon National Registry   1998–2007 4 1998–2007 0
Libya Benghazi   2003–2005 3 2003–2005 0
Lithuania National Registry   1978–2011 33 1978–2011 2
Malawi Blantyre   1994–2007 10 1994–2007 0
Malaysia National Registry   2003 1 2003 0
Malaysia Penang   1998–2007 9 1998–2007 0
Malaysia Sarawak   1998–2002 5 1998–2002 0
Mali Bamako   1987–1996 11 1987–1996 0
Malta National Registry   1969–2010 27 1969–2010 15
Mongolia National Registry   2003–2007 0 2003–2007 0
Morocco Greater Casablanca   2004 1 2004 0
Mozambique Lourenco Marques   1956–1960 0 1956–1960 0
Namibia National Registry   2000–2009 10 2000–2009 0
Netherlands Eindhoven   1973–2007 27 1973–2007 0
Netherlands Maastricht   1986–2002 3 1986–2002 0
Netherlands National Registry   1989–2015 19 1989–2007 0
Netherlands Three Provinces   1960–1962 0 1960–1962 0
New Zealand National Registry   1968–2014 32 1983–2014 5
Nigeria Calabar   2009–2013 5 2009–2013 0
Nigeria Ibadan   1960–1969 0 1960–1969 0
Nigeria Midwestern Nigeria   NA NA 2008–2009 0
Norway National Registry   1953–2014 50 1953–2014 35
Oman National Registry   1993–2012 20 1993–2012 0
Pakistan South Karachi   1995–2002 8 1995–2002 0
Palestine West Bank   2010–2011 2 2010–2011 0
Panama National Registry   1988–2011 23 1988–2011 12
Paraguay Asuncion Region   1988–1989 2 1988–1989 0
Peru Lima   1990–1991 2 1990–1991 0
Peru Trujillo   1984–2002 19 1984–2002 1
Philippines Manila   1983–2007 25 1983–2007 0
Philippines Rizal   1978–2007 20 1978–2007 0
Poland Cieszyn   1968–1977 5 1973–1977 0
Poland Cieszyn and NowySacz   1968–1972 5 1968–1972 0
Poland Cracow   1968–2006 26 1973–2006 0
Poland Cracow City and District   1965–1972 5 1965–1972 0
Poland Four Rural Areas   1965–1966 0 1965–1966 0
Poland Katowice   1965–1977 5 1965–1974 0
Poland Kielce   1988–2007 13 1988–2007 0
Poland Lower Silesia   1984–2007 14 1984–2007 0
Poland National Registry   1999–2011 13 1999–2011 13
Poland NowySacz   1973–1986 13 1973–1986 0
Poland Opole   1985–1987 3 1985–1987 0
Poland Rzeszow   2003–2007 0 2003–2007 0
Poland Warsaw   1988–2002 11 1988–2002 0
Poland Warsaw Rural   1968–1987 15 1968–1987 0
Poland Warsaw Urban   1965–2002 27 1965–2002 0
Portugal Azores   1997–2011 14 1981–2012 15
Portugal Centre   2003–2007 5 2003–2007 5
Portugal North Portugal   2000–2006 7 2000–2006 7
Portugal Porto   1998–2002 5 1998–2002 0
Portugal South Portugal   1998–2007 10 1998–2007 0
Portugal Vila Nova de Gaia   1983–1997 10 1983–1997 0
Puerto Rico National Registry   NA 26 NA NA
Qatar National Registry   2003–2007 5 2003–2007 0
Romania Banat Region   1967 0 1967 0
Romania Cluj   2007 1 2007 1
Romania County Cluj   1974–1987 14 1974–1987 0
Romania County Timis   1970–1972 3 1970–1972 0
Romania Timisoara   2008 1 2008 0
Russia St Petersburg   1983–2007 19 1983–2007 0
Samoa National Registry   1980–1988 9 1980–1988 0
Saudi Arabia National Registry   1994–2012 10 1994–2012 0
Saudi Arabia Riyadh   2003–2007 5 2003–2007 0
Senegal Dakar   1969–1974 6 1969–1974 0
Serbia Central Serbia   2003–2007 4 2003–2007 5
Serbia National Registry   1999–2002 4 1999–2002 0
Serbia Vojvodina   1988–1997 10 1988–1997 0
Seychelles National Registry   2009–2011 3 2009–2011 0
Singapore National Registry   1950–2008 44 1950–2008 0
Slovakia National Registry   1968–2007 42 1968–2010 30
Slovenia National Registry   1956–2010 49 1956–2010 8
South Africa Johannesburg, Bantu   1953–1955 0 1953–1955 0
South Africa National Registry   2003–2011 4 2003–2011 0
South Africa PROMEC   1998–2007 10 1998–2007 0
South Korea Busan   1996–2007 2 1996–2007 0
South Korea Daegu   1997–2007 2 1997–2007 0
South Korea Daejeon   1998–2007 0 1998–2007 0
South Korea Gwangju   1998–2007 0 1998–2007 0
South Korea Incheon   1998–2007 0 1998–2007 0
South Korea Jejudo   2000–2007 3 2000–2007 0
South Korea Kangwha County   1986–1997 12 1986–1997 0
South Korea National Registry   1999–2012 12 1999–2012 0
South Korea Seoul   1993–2007 5 1993–2007 0
South Korea Ulsan   1999–2007 0 1999–2007 0
Spain Albacete   1991–2007 16 1991–2007 6
Spain Asturias   1988–2007 17 1988–2007 5
Spain Balears   1988–2005 18 1988–2005 0
Spain Basque Country   1986–2007 20 1986–2008 4
Spain Canary Islands   1993–2006 10 1993–2006 0
Spain Ciudad Real   2004–2007 4 2004–2007 0
Spain Cuenca   1993–2007 15 1993–2007 5
Spain Girona   1980–2007 27 1980–2008 23
Spain Granada   1985–2007 22 1985–2007 23
Spain La Rioja   1993–2007 12 1993–2007 13
Spain Mallorca   1988–2007 14 1988–2007 0
Spain Murcia   1983–2007 24 1983–2007 25
Spain Navarra   1973–2007 32 1973–2008 31
Spain Tarragona   1980–2007 25 1980–2007 24
Spain Zaragoza   1968–2000 33 1968–2000 0
Sri Lanka National Registry   2001–2005 6 2001–2005 0
Sweden National Registry   1958–2014 50 1958–2014 35
Sweden Stockholm   1990–2010 21 1990–2010 0
Sweden Sweden except Stockholm   1990–2010 21 1990–2010 0
Switzerland Basel   1981–2007 7 1981–2007 0
Switzerland Geneva   1970–2008 19 1970–2008 29
Switzerland Graubunden   1989–1997 0 1989–1997 0
Switzerland Graubunden and Glarus   1989–2009 0 1980–2009 20
Switzerland National Registry   1986–2013 25 1989–2013 0
Switzerland Neuchatel   1974–2007 13 1974–2008 5
Switzerland St Gallen – Appenzell   1980–2009 9 1980–2009 29
Switzerland Ticino   1996–2007 0 1996–2007 0
Switzerland Valais   1989–2007 0 1989–2007 0
Switzerland Vaud   1975–2007 13 1975–2008 5
Switzerland Zurich   1980–2009 9 1980–2009 0
Taiwan National Registry   1980–2007 28 1980–2007 28
Thailand Bangkok   1995–2007 11 1995–2007 0
Thailand Chiang Mai   1983–2007 29 1983–2007 0
Thailand Chonburi   2001–2007 8 2001–2007 0
Thailand KhonKaen   1988–2007 19 1988–2007 0
Thailand Lampang   1993–2007 18 1993–2007 0
Thailand Lop Buri   2001–2003 3 2001–2003 0
Thailand NakhonPhanom   2001–2003 3 2001–2003 0
Thailand PrachuapKhiri   2001–2003 3 2001–2003 0
Thailand Rayong   2001–2003 3 2001–2003 0
Thailand Songkhla   1993–2007 16 1993–2007 0
Thailand SuratThani   2001–2003 3 2001–2003 0
Thailand UbonRatchathani   2001–2003 3 2001–2003 0
Thailand UdonThani   2001–2003 3 2001–2003 0
The Gambia National Registry   1987–1998 15 1987–1998 0
Trinidad and Tobago National Registry   1995–2006 12 1995–2006 12
Tunisia Centre Sousse   1998–2002 5 1998–2002 0
Tunisia North Tunisia   2003–2005 3 2003–2005 0
Turkey Ankara   2002–2005 4 2002–2005 0
Turkey Antalya   1998–2008 13 1998–2008 0
Turkey Edirne   2002–2007 6 2002–2007 0
Turkey Eight Provinces   2006–2007 2 2006–2007 0
Turkey Erzurum   2002–2005 4 2002–2005 0
Turkey Eskisehir   2002–2005 4 2002–2005 0
Turkey Izmir   1998–2008 14 1998–2008 0
Turkey Nine Provinces   2008 1 2008 0
Turkey Samsun   2002–2005 4 2002–2005 0
Turkey Trabzon   2002–2007 5 2002–2007 0
Uganda Kampala   1954–2013 24 1954–2013 0
Ukraine National Registry   2000–2010 7 2000–2010 4
United Kingdom Aryshire   1970–1972 3 1970–1972 0
United Kingdom East Anglia   1988–1997 0 1988–1997 0
United Kingdom East Midlands   1981–2014 34 1981–2014 20
United Kingdom East Scotland   1973–1987 5 1973–1987 0
United Kingdom East of England   1981–2014 33 1981–2014 20
United Kingdom England   1993–2007 10 1993–2007 0
United Kingdom England and Wales   1979–1990 0 1979–1990 0
United Kingdom Greater London   1981–2014 34 1981–2014 20
United Kingdom Merseyside and Cheshire   1959–2002 11 1959–2002 0
United Kingdom North East England   1981–2014 34 1981–2014 20
United Kingdom North East Scotland   1973–1987 5 1973–1987 0
United Kingdom North Scotland   1973–1987 5 1973–1987 0
United Kingdom North West England   1973–2014 40 1973–2014 20
United Kingdom Northern England and Yorkshire   1998–2007 0 1998–2007 0
United Kingdom Northern Ireland   1993–2011 18 1993–2011 0
United Kingdom Oxford   1963–2007 18 1963–2007 0
United Kingdom Scotland   1963–2014 40 1963–2014 25
United Kingdom South East England   1981–2014 34 1981–2014 20
United Kingdom South East Scotland   1973–1987 5 1973–1987 0
United Kingdom South Thames   1960–2007 20 1960–1997 0
United Kingdom South West England   1960–2014 37 1960–2014 20
United Kingdom Thames   1998–2007 0 1991–2007 0
United Kingdom Trent   1963–2007 3 1963–2007 0
United Kingdom Wales   1981–2011 31 1981–2011 20
United Kingdom Wessex   1988–1992 0 1988–1992 0
United Kingdom West Midlands   1960–2014 44 1960–2014 20
United Kingdom West Scotland   1975–1992 0 1975–1992 0
United Kingdom Yorkshire   1983–2002 7 1983–2002 0
United Kingdom Yorkshire and the Humber   1981–2014 34 1981–2014 20
United States Alabama   1998–2011 10 1998–2007 0
United States Alameda County   1969–1987 5 1983–1987 0
United States Alaska   1998–2011 10 1998–2007 0
United States Alaska Natives   1992–2013 0 NA NA
United States Arizona   1998–2011 10 1998–2007 0
United States Arkansas   2001–2011 5 2003–2007 0
United States Atlanta   1973–2013 39 1973–2013 36
United States California   1998–2011 10 1998–2007 0
United States California except SF, SJ–M, & LA   2000–2013 14 2000–2013 9
United States Central California   1988–1992 5 1988–1992 0
United States Colorado   1998–2011 10 1998–2007 0
United States Connecticut   1960–2013 41 1960–2013 37
United States Delaware   1999–2011 5 2003–2007 0
United States Detroit   1969–2013 41 1973–2013 37
United States District of Columbia   1998–2011 5 1998–2002 0
United States El Paso   1960–1970 0 1960–1970 0
United States Florida   1998–2011 10 1998–2007 0
United States Georgia   1998–2011 10 1998–2007 0
United States Greater Georgia   1973–2013 14 1973–2013 13
United States Hawaii   1960–2013 46 1960–2013 37
United States Idaho   1998–2011 10 1998–2007 0
United States Illinois   1998–2011 10 1998–2007 0
United States Indiana   1998–2011 10 1998–2007 0
United States Iowa   1969–2013 41 1973–2013 37
United States Kansas   1999–2011 0 NA NA
United States Kentucky   1973–2013 19 1973–2013 19
United States Los Angeles   1973–2013 41 1973–2013 24
United States Louisiana   1973–2013 29 1973–2013 18
United States Maine   1998–2011 10 1998–2007 0
United States Maryland   1999–2011 0 NA NA
United States Massachusetts   1998–2011 10 1998–2007 0
United States Michigan   1998–2011 10 1998–2007 0
United States Minnesota   1999–2011 0 NA NA
United States Mississippi   2003–2011 5 2003–2007 0
United States Missouri   1998–2011 10 1998–2007 0
United States Montana   1998–2011 10 1998–2007 0
United States National Registry   1962–2007 0 1962–2007 0
United States Nebraska   1999–2011 5 2003–2007 0
United States Nevada   1959–2010 0 1959–1966 0
United States New Hampshire   1999–2011 5 2003–2007 0
United States New Jersey   1973–2013 24 1973–2013 19
United States New Mexico   1969–2013 45 1969–2013 37
United States New Orleans   1974–2007 17 1983–2007 0
United States New York   1993–2011 15 1993–2007 0
United States New York City   1978–1987 0 NA NA
United States New York except New York City   1959–1987 0 1959–1961 0
United States North Carolina   1999–2011 5 2003–2007 0
United States North Dakota   1999–2011 5 2003–2007 0
United States Ohio   1998–2011 10 1998–2007 0
United States Oklahoma   1998–2011 10 1998–2007 0
United States Oregon   1998–2011 10 1998–2007 0
United States Pennsylvania   1998–2011 10 1998–2007 0
United States Rhode Island   1998–2011 10 1998–2007 0
United States Rural Georgia   1973–2013 22 1973–2013 24
United States San Francisco   1969–2007 29 1973–2007 0
United States San Francisco, Oakland, San Mateo, and Surrounding Area   1973–2013 41 1973–2013 36
United States San Jose Monterey   1973–2013 22 1973–2013 24
United States Seattle   1973–2013 40 1973–2013 36
United States South Carolina   1998–2011 10 1998–2007 0
United States South Dakota   2001–2011 5 2003–2007 0
United States Tennessee   2003–2011 5 2003–2007 0
United States Texas   1998–2011 10 1998–2007 0
United States Utah   1966–2013 41 1973–2013 37
United States Vermont   1998–2011 10 1998–2007 0
United States Virginia   2003–2011 5 2003–2007 0
United States Washington   1998–2011 10 1998–2007 0
United States West Virginia   1998–2011 10 1998–2007 0
United States Wisconsin   1998–2011 10 1998–2007 0
United States Wyoming   1999–2011 5 2003–2007 0
Uruguay Montevideo   1990–1995 6 1990–1995 0
Uruguay National Registry   2002–2007 8 2002–2007 0
Vietnam Hanoi   1991–1997 8 1991–1997 0
Vietnam Ho Chi Minh   1995–1998 4 1995–1998 0
Zimbabwe Bulawayo   1963–1972 5 1963–1972 0
Zimbabwe Harare   1990–2006 17 1990–2006 0
Zimbabwe National Registry   2005–2006 2 2005–2006 0

NA, not available.

Table S2. Number of site-years for bladder cancer mortality data.

Cause VR GBD 2015 VR GBD 2016 VR change GBD 2015 to GBD 2016 VA GBD 2015 VA GBD 2016 VA change GBD 2015 to GBD 2016 CR GBD 2015 CR GBD 2016 CR change GBD 2015 to GBD 2016 Total GBD 2015 Total GBD 2016 Total change GBD 2015 to GBD 2016
Bladder cancer 10,100 16,010 59% 2,426 2,656 9% 12,526 18,666 49%

GBD, Global Burden of Disease; VR, vital registration system data; VA, verbal autopsy data; CR, cancer registry data.

Table S3. Sociodemographic Index groupings by geography, based on 2016 values.

Location SDI quintile
Andorra High SDI
Australia High SDI
Austria High SDI
Belgium High SDI
Brunei High SDI
Canada High SDI
Croatia High SDI
Cyprus High SDI
Czech Republic High SDI
Denmark High SDI
Estonia High SDI
Finland High SDI
France High SDI
Georgia High SDI
Germany High SDI
Greece High SDI
Iceland High SDI
Ireland High SDI
Italy High SDI
Japan High SDI
Latvia High SDI
Lithuania High SDI
Luxembourg High SDI
Malta High SDI
Netherlands High SDI
New Zealand High SDI
Norway High SDI
Poland High SDI
Puerto Rico High SDI
Singapore High SDI
Slovakia High SDI
Slovenia High SDI
South Korea High SDI
Sweden High SDI
Switzerland High SDI
Taiwan High SDI
United Kingdom High SDI
United States High SDI
Virgin Islands, United States High SDI
Antigua and Barbuda High‐middle SDI
Argentina High‐middle SDI
Armenia High‐middle SDI
Azerbaijan High‐middle SDI
Barbados High‐middle SDI
Belarus High‐middle SDI
Bermuda High‐middle SDI
Bulgaria High‐middle SDI
Chile High‐middle SDI
Cuba High‐middle SDI
Georgia High‐middle SDI
Greenland High‐middle SDI
Guam High‐middle SDI
Hungary High‐middle SDI
Iran High‐middle SDI
Israel High‐middle SDI
Kazakhstan High‐middle SDI
Kuwait High‐middle SDI
Lebanon High‐middle SDI
Libya High‐middle SDI
Macedonia High‐middle SDI
Malaysia High‐middle SDI
Mauritius High‐middle SDI
Montenegro High‐middle SDI
Northern Mariana Islands High‐middle SDI
Panama High‐middle SDI
Portugal High‐middle SDI
Qatar High‐middle SDI
Romania High‐middle SDI
Russia High‐middle SDI
Saudi Arabia High‐middle SDI
Serbia High‐middle SDI
Spain High‐middle SDI
The Bahamas High‐middle SDI
Trinidad and Tobago High‐middle SDI
Turkey High‐middle SDI
Turkmenistan High‐middle SDI
Ukraine High‐middle SDI
United Arab Emirates High‐middle SDI
Albania Middle SDI
Algeria Middle SDI
American Samoa Middle SDI
Bahrain Middle SDI
Bosnia and Herzegovina Middle SDI
Botswana Middle SDI
Brazil Middle SDI
China Middle SDI
Colombia Middle SDI
Costa Rica Middle SDI
Dominica Middle SDI
Dominican Republic Middle SDI
Ecuador Middle SDI
Egypt Middle SDI
El Salvador Middle SDI
Equatorial Guinea Middle SDI
Fiji Middle SDI
Grenada Middle SDI
Guyana Middle SDI
Indonesia Middle SDI
Jamaica Middle SDI
Jordan Middle SDI
Maldives Middle SDI
Mexico Middle SDI
Moldova Middle SDI
Mongolia Middle SDI
Oman Middle SDI
Paraguay Middle SDI
Peru Middle SDI
Philippines Middle SDI
Saint Lucia Middle SDI
Saint Vincent and the Grenadines Middle SDI
Seychelles Middle SDI
South Africa Middle SDI
Sri Lanka Middle SDI
Suriname Middle SDI
Thailand Middle SDI
Tunisia Middle SDI
Uruguay Middle SDI
Uzbekistan Middle SDI
Venezuela Middle SDI
Vietnam Middle SDI
Bangladesh Low‐middle SDI
Belize Low‐middle SDI
Bhutan Low‐middle SDI
Bolivia Low‐middle SDI
Cambodia Low‐middle SDI
Cameroon Low‐middle SDI
Cape Verde Low‐middle SDI
Congo Low‐middle SDI
Federated States of Micronesia Low‐middle SDI
Gabon Low‐middle SDI
Ghana Low‐middle SDI
Guatemala Low‐middle SDI
Honduras Low‐middle SDI
India Low‐middle SDI
Iraq Low‐middle SDI
Kenya Low‐middle SDI
Kyrgyzstan Low‐middle SDI
Laos Low‐middle SDI
Lesotho Low‐middle SDI
Marshall Islands Low‐middle SDI
Mauritania Low‐middle SDI
Morocco Low‐middle SDI
Myanmar Low‐middle SDI
Namibia Low‐middle SDI
Nepal Low‐middle SDI
Nicaragua Low‐middle SDI
Nigeria Low‐middle SDI
North Korea Low‐middle SDI
Pakistan Low‐middle SDI
Samoa Low‐middle SDI
Sudan Low‐middle SDI
Swaziland Low‐middle SDI
Syria Low‐middle SDI
Tajikistan Low‐middle SDI
Timor-Leste Low‐middle SDI
Tonga Low‐middle SDI
Vanuatu Low‐middle SDI
Zambia Low‐middle SDI
Zimbabwe Low‐middle SDI
Afghanistan Low SDI
Angola Low SDI
Benin Low SDI
Burkina Faso Low SDI
Burundi Low SDI
Central African Republic Low SDI
Chad Low SDI
Comoros Low SDI
Cote d’Ivoire Low SDI
Democratic Republic of the Congo Low SDI
Djibouti Low SDI
Eritrea Low SDI
Ethiopia Low SDI
Guinea Low SDI
Guinea-Bissau Low SDI
Haiti Low SDI
Kiribati Low SDI
Liberia Low SDI
Madagascar Low SDI
Malawi Low SDI
Mali Low SDI
Mozambique Low SDI
Niger Low SDI
Palestine Low SDI
Papua New Guinea Low SDI
Rwanda Low SDI
Sao Tome and Principe Low SDI
Senegal Low SDI
Sierra Leone Low SDI
Solomon Islands Low SDI
Somalia Low SDI
South Sudan Low SDI
Tanzania Low SDI
The Gambia Low SDI
Togo Low SDI
Uganda Low SDI
Yemen Low SDI

SDI, sociodemographic index.

Table S4. Covariates selected for CODEm for each GBD bladder cancer group and expected direction of covariate.

Cause Sex Age start Age end Direction Covariate
Bladder cancer Male 15–19 years 95+ years 1 Alcohol (liters per capita)
Bladder cancer Male 15–19 years 95+ years 1 cumulative cigarettes (10 years)
Bladder cancer Male 15–19 years 95+ years 1 cumulative cigarettes (15 years)
Bladder cancer Male 15–19 years 95+ years 1 cumulative cigarettes (5 years)
Bladder cancer Male 15–19 years 95+ years −1 Education (years per capita)
Bladder cancer Male 15–19 years 95+ years 0 LDI (I$ per capita)
Bladder cancer Male 15–19 years 95+ years 1 Population density (over 1,000 ppl/sqkm, proportion)
Bladder cancer Male 15–19 years 95+ years 1 Population density (under 150 ppl/sqkm, proportion)
Bladder cancer Male 15–19 years 95+ years 1 Smoking prevalence
Bladder cancer Male 15–19 years 95+ years 1 Log-transformed SEV scalar: Bladder C
Bladder cancer Male 15–19 years 95+ years 0 Sociodemographic index
Bladder cancer Male 15–19 years 95+ years −1 fruits adjusted (g)
Bladder cancer Male 15–19 years 95+ years −1 Vegetables adjusted (g)
Bladder cancer Male 15–19 years 95+ years −1 Healthcare access and quality index
Bladder cancer Female 15–19 years 95+ years 1 Alcohol (liters per capita)
Bladder cancer Female 15–19 years 95+ years 1 Cumulative cigarettes (10 years)
Bladder cancer Female 15–19 years 95+ years 1 Cumulative cigarettes (15 years)
Bladder cancer Female 15–19 years 95+ years 1 Cumulative cigarettes (5 years)
Bladder cancer Female 15–19 years 95+ years −1 Education (years per capita)
Bladder cancer Female 15–19 years 95+ years 0 LDI (I$ per capita)
Bladder cancer Female 15–19 years 95+ years 1 Population density (over 1,000 ppl/sqkm, proportion)
Bladder cancer Female 15–19 years 95+ years 1 Population density (under 150 ppl/sqkm, proportion)
Bladder cancer Female 15–19 years 95+ years 1 Smoking prevalence
Bladder cancer Female 15–19 years 95+ years 1 Log‐transformed SEV scalar: Bladder C
Bladder cancer Female 15–19 years 95+ years 0 Sociodemographic index
Bladder cancer Female 15–19 years 95+ years −1 fruits adjusted (g)
Bladder cancer Female 15–19 years 95+ years −1 Vegetables adjusted (g)
Bladder cancer Female 15–19 years 95+ years −1 Healthcare access and quality index

CODEm, cause of death ensemble model; GBD, Global Burden of Disease.

Table S5. Comparison of GBD 2015 and GBD 2016 covariates used and level of covariates.

Cause Sex Covariate GBD 2015 GBD 2016
Level 1 Level 2 Level 3 Level 1 Level 2 Level 3
Bladder cancer Male Cumulative cigarettes (10 years) X X
Bladder cancer Male Cumulative cigarettes (15 years) X X
Bladder cancer Male Cumulative cigarettes (5 years) X X
Bladder cancer Male Education (years per capita) X X
Bladder cancer Male LDI (I$ per capita) X X
Bladder cancer Male Sociodemographic index X X
Bladder cancer Male Smoking prevalence X X
Bladder cancer Male Alcohol (liters per capita) X X
Bladder cancer Male Log‐transformed SEV scalar: Bladder C X X
Bladder cancer Male Population density (under 150 ppl/sqkm, proportion) X X
Bladder cancer Male Population density (over 1,000 ppl/sqkm, proportion) X X
Bladder cancer Female Cumulative cigarettes (10 years) X X
Bladder cancer Female Cumulative cigarettes (15 years) X X
Bladder cancer Female Cumulative cigarettes (5 years) X X
Bladder cancer Female Education (years per capita) X X
Bladder cancer Female LDI (I$ per capita) X X
Bladder cancer Female Sociodemographic index X X
Bladder cancer Female Smoking prevalence X X
Bladder cancer Female Alcohol (liters per capita) X X
Bladder cancer Female Log‐transformed SEV scalar: Bladder C X X
Bladder cancer Female Population density (under 150 ppl/sqkm, proportion) X X
Bladder cancer Female Population density (over 1,000 ppl/sqkm, proportion) X X

GBD, Global Burden of Disease.

Table S6. Results for CODEm model testing.

Cause Sex Age start Age end Predictive validity
RMSE in RMSE out Trend in Trend out Coverage in Coverage out
Bladder cancer (data rich) Male 15–19 years 95+ years 0.238162 0.289199 0.193221 0.21405 0.998893 0.9979
Bladder cancer (global) Male 15–19 years 95+ years 0.259512 0.358356 0.20438 0.211875 0.998849 0.993972
Bladder cancer (global) Female 15–19 years 95+ years 0.279362 0.406151 0.217047 0.218843 0.995797 0.992228
Bladder cancer (data rich) Female 15–19 years 95+ years 0.241778 0.308128 0.197425 0.236098 0.995139 0.99458

CODEm, cause of death ensemble model; RMSE, root mean square of errors.

Table S7. Percent change before and after Cod Correct by bladder cancer for all ages, both sexes combined, 2016.

Cause Cod Correct level Percent change (%)
Bladder cancer 3 −2.19 (−3.56 to −0.52)

Table S8. Disability weights.

Health state Lay description Estimate Uncertainty interval
Cancer, diagnosis and primary therapy Has pain, nausea, fatigue, weight loss and high anxiety 0.288 0.193–0.399
Cancer, controlled phase Has a chronic disease that requires medication every day and causes some worry but minimal interference with daily activities 0.049 0.031–0.072
Cancer, metastatic Has severe pain, extreme fatigue, weight loss and high anxiety 0.451 0.307–0.600
Terminal phase, with medication Has lost a lot of weight and regularly uses strong medication to avoid constant pain. The person has no appetite, feels nauseous, and needs to spend most of the day in bed 0.540 0.377–0.687

Table S9. Decomposition analysis of bladder cancer incidence trends at the global and regional levels, and by SDI quintiles, both sexes, 2006 to 2016.

Location Incidence cases, No. Expected incidence cases, 2016, No. Change in incidence cases, 2006 to 2016, % Overall change, %
2006 2016 Given population growth alone Given population growth and aging Due to population growth Due to change in age structure Due to change in incidence rate
Global 333,876 (329,918 to 337,714) 437,442 (426,709 to 447,912) 375,373 441,586 12.4 19.8 −1.2 31
High SDI 171,627 (169,324 to 173,991) 213,500 (206,159 to 220,038) 180,794 213,267 5.3 18.9 0.1 24.4
High‐middle SDI 76,815 (75,044 to 78,668) 96,865 (93,605 to 100,135) 85,342 99,392 11.1 18.3 −3.3 26.1
Middle SDI 56,859 (55,417 to 58,408) 85,371 (80,381 to 87,836) 61,034 77,034 7.3 28.1 14.7 50.1
Low‐middle SDI 23,940 (22,710 to 25,170) 34,771 (32,913 to 36,384) 27,918 32,388 16.6 18.7 10 45.2
Low SDI 6,011 (5,650 to 6,672) 8,223 (7,850 to 8,585) 7,952 8,197 32.3 4.1 0.4 36.8

SDI, sociodemographic index.

The GBD estimation process starts with cancer mortality. Data sources for bladder cancer mortality include vital registration systems and cancer registries. Cancer incidence data are used to model mortality in places where without cancer mortality data by multiplying incidence by a separately modelled mortality-to incidence ratio. These mortality estimates are used in a cause of death ensemble model (CODEm) (7,11). Each cancer type is estimated separately using covariates with a causal connection. Cancer incidence is estimated by dividing final cancer-specific mortality estimates by the mortality-to-incidence ratio. We also estimated the contributions of population ageing, population growth, and the change in age-specific rates on the change of incident cases between 2006 and 2016, which are available in the Supplementary materials (6).

Results

Trends in bladder cancer incidence in the period from 1990 to 2016

Globally, new bladder cancer diagnoses rose 1.8-fold between 1990 and 2016 {238,617 [95% uncertainty interval (UI), 232,159–244,362] to 437,442 (95% UI, 426,709–447,912)}. In 2016, in relation to SDI countries, the highest bladder cancer incidence in both men and women occurred in high SDI countries (213,500, 95% UI, 206,159–220,038), followed by high-middle SDI countries (96,865; 95% UI, 93,605–100,135), middle SDI countries (85,371; 95% UI, 80,381–87,836), low-middle SDI countries (34,771; 95% UI, 32,913–36,384), and low SDI countries (8,223; 95% UI, 7,850–8,585). In the same year, 334,373 (95% UI, 325,085–342,168) and 103,069 (95% UI, 98,687–107,068) incident cases were estimated for males and females, respectively. In terms of SDI countries, the largest increase (162.60%) was in middle SDI countries [from 32,510 (95% UI, 31,501–34,224) in 1990 to 85,371 (95% UI, 80,381–87,836) in 2016]. Among the regions, the largest increase in bladder cancer incident cases from 1990 to 2016 was in Oceania, with a rise of 259.52% [from 42 (95% UI, 37–55) in 1990 to 151 (95% UI, 133–185) in 2016]. In 2016, bladder cancer was more common in men, with 334,373 incident cases compared to women, with 103,069 cases (Table 1).

Table 1. Global and regional bladder cancer incident and death cases by geography, gender, and SDI, 1990 and 2016.

Location Incident cases, global and regional Death cases, global and regional
1990 2016 1990 2016
Male Female Both Male Female Both Male Female Both Male Female Both
Global 179,438 [174,049–184,282] 59,179 [57,539–60,890] 238,617 [232,159–244,362] 334,373 [325,085–342,168] 103,069 [98,687–107,068] 437,442 [426,709–447,912] 81,981 [79,064–85,004] 31,433 [30,267–32,783] 113,414 [110,361–117,066] 137,883 [133,054–142,437] 48,315 [46,028–50,487] 186,199 [180,453–191,686]
High SDI 101,014 [99,063–103,041] 32,979 [32,367–33,606] 133,992 [131,968–136,064] 161,396 [154,512–166,577] 52,104 [49,679–54,630] 213,500 [206,159–220,038] 35,703 [35,030–36,370] 14,346 [14,031–14,669] 50,049 [49,298–50,885] 54,949 [52,530–57,085] 20,387 [19,284–21,390] 75,336 [72,679–77,841]
High-middle SDI 43,298 [39,889–45,673] 11,490 [10,833–12,202] 54,788 [51,061–57,281] 77,144 [74,433–79,912] 19,721 [18,543–20,826] 96,865 [93,605–100,135] 20,432 [18,799–21,725] 5,790 [5,482–6,115] 26,223 [24,462–27,545] 30,484 [28,212–32,743] 8,404 [7,598–9,352] 38,889 [36,379–41,379]
Low SDI 2,512 [2,361–2,905] 1,513 [1,303–1,797] 4,025 [3,709–4,547] 5,193 [4,866–5,488] 3,030 [2,848–3,239] 8,223 [7,850–8,585] 2,489 [2,236–2,930] 1,510 [1,286–1,809] 3,999 [3,631–4,545] 5,274 [4,773–5,712] 3,046 [2,723–3,346] 8,320 [7,757–8,853]
Low-middle SDI 9,893 [8,765–10,706] 4,498 [4,029–5,279] 14,391 [12,928–15,622] 25,581 [23,840–27,099] 9,190 [8,856–9,530] 34,771 [32,913–36,384] 7,189 [6,256–7,946] 3,662 [3,082–4,402] 10,851 [9,872–11,959] 15,795 [14,474–17,080] 6,516 [5,972–7,038] 22,311 [20,831–23,545]
Middle SDI 23,751 [23,023–25,145] 8,759 [8,342–9,217] 32,510 [31,501–34,224] 66,277 [62,215–68,205] 19,094 [17,794–20,156] 85,371 [80,381–87,836] 16,144 [15,408–17,259] 6,111 [5,744–6,443] 22,254 [21,368–23,483] 31,314 [29,333–32,668] 9,934 [9,182–10,567] 41,248 [38,787–42,863]
High-income Asia Pacific 8,994 [8,746–9,250] 3,114 [3,027–3,197] 12,108 [11,837–12,374] 21,513 [19,918–22,754] 7,581 [7,129–8,098] 29,094 [27,312–30,653] 2,875 [2,781–2,978] 1,308 [1,266–1,355] 4,183 [4,080–4,303] 7,038 [6,440–7,622] 3,030 [2,793–3,291] 10,067 [9,365–10,749]
Western Europe 64,281 [62,445–66,177] 18,395 [17,896–18,909] 82,676 [80,720–84,679] 91,848 [86,389–96,142] 25,886 [24,239–27,686] 117,734 [111,908–122,735] 23,439 [22,820–24,061] 8,642 [8,365–8,915] 32,081 [31,398–32,778] 32,283 [30,396–34,059] 10,672 [9,930–11,416] 42,955 [40,983–44,950]
Andean Latin 269 [253–289] 142 [126–160] 411 [385–443] 622 [581–667] 356 [331–381] 978 [935–1,023] 189 [172–206] 100 [87–116] 288 [266–315] 391 [337–452] 225 [189–265] 616 [550–687]
America 1,221 [1,184–1,260] 644 [624–666] 1,865 [1,818–1,910] 3,644 [3,539–3,759] 1,995 [1,871–2,072] 5,639 [5,494–5,778] 785 [758–814] 420 [404–437] 1,205 [1,172–1,239] 1,769 [1,673–1,873] 977 [904–1,038] 2,747 [2,624–2,870]
Central Latin America 2,412 [2,274–2,557] 624 [581–669] 3,036 [2,887–3,192] 3,901 [3,619–4,187] 1,466 [1,346–1,596] 5,367 [5,050–5,682] 1,370 [1,272–1,467] 397 [364–431] 1,766 [1,664–1,869] 1,781 [1,577–1,992] 762 [662–874] 2,543 [2,317–2,792]
Southern Latin America 2,131 [2,058–2,204] 820 [786–855] 2,952 [2,869–3,038] 6,311 [6,047–6,574] 2,942 [2,776–3,100] 9,253 [8,945–9,559] 1,334 [1,273–1,399] 519 [493–546] 1,853 [1,786–1,924] 3,234 [3,034–3,427] 1,482 [1,375–1,594] 4,715 [4,490–4,947]
Tropical Latin America 7,453 [6,903–8,204] 1,864 [1,661–2,086] 9,316 [8,680–10,212] 22,984 [21,176–24,621] 5,142 [4,743–5,619] 28,126 [26,065–30,002] 5,002 [4,479–5,615] 1,268 [1,106–1,454] 6,270 [5,624–6,986] 10,655 [9,643–11,721] 2,496 [2,278–2,775] 13,152 [12,143–14,214]
North Africa and Middle 27,248 [26,618–27,875] 10,465 [10,158–10,789] 37,712 [36,932–38,481] 46,158 [44,662–47,633] 15,905 [15,200–16,620] 62,062 [60,383–63,707] 8,929 [8,698–9,161] 4,046 [3,921–4,175] 12,975 [12,688–13,262] 15,028 [14,427–15,637] 5,891 [5,605–6,216] 20,919 [20,235–21,653]
East 27 [25–36] 15 [12–20] 42 [37–55] 97 [88–119] 54 [42–70] 151 [133–185] 18 [15–24] 11 [8–16] 29 [24–38] 47 [40–63] 32 [23–44] 78 [64–103]
High-income North America 375 [324–464] 238 [197–290] 613 [533–718] 744 [676–815] 432 [381–490] 1,176 [1,100–1,256] 340 [271–428] 219 [179–273] 559 [465–662] 705 [605–820] 424 [363–487] 1,130 [1,009–1,264]
Oceania 1,050 [975–1,146] 809 [699–942] 1,859 [1,725–1,999] 2,335 [2,060–2,538] 1,758 [1,479–2,089] 4,094 [3,567–4,514] 1,069 [954–1,203] 835 [692–1,002] 1,904 [1,722–2,108] 2,375 [2,036–2,656] 1,739 [1,411–2,077] 4,115 [3,529–4,533]
Central sub-Saharan 1,572 [1,303–1,742] 400 [350–460] 1,972 [1,659–2,166] 2,500 [2,328–2,647] 552 [511–597] 3,052 [2,860–3,217] 789 [656–889] 219 [190–257] 1,008 [851–1,118] 1,090 [985–1,197] 250 [225–277] 1,339 [1,232–1,457]
Africa 844 [718–954] 574 [518–617] 1,418 [1,247–1,547] 1,623 [1,458–1,771] 988 [930–1,047] 2,611 [2,410–2,789] 490 [373–590] 334 [278–383] 824 [657–954] 879 [773–977] 528 [461–598] 1,407 [1,275–1,540]
Eastern sub-Saharan 1,199 [1,140–1,280] 558 [513–604] 1,757 [1,670–1,872] 2,163 [2,060–2,256] 967 [869–1,052] 3,129 [2,959–3,268] 1,206 [1,082–1,343] 583 [516–662] 1,789 [1,630–1,961] 2,120 [1,922–2,362] 941 [811–1,081] 3,061 [2,794–3,363]
Africa 18,715 [17,988–19,829] 6,821 [6,436–7,230] 25,536 [24,567–26,906] 51,759 [48,743–53,797] 12,867 [11,731–14,081] 64,626 [60,665–67,499] 12,258 [11,642–13,087] 4,756 [4,386–5,105] 17,014 [16,205–17,924] 21,531 [20,229–22,538] 6,070 [5,517–6,665] 27,601 [25,919–28,929]
Central Asia 8,119 [7,279–8,781] 3,215 [2,891–3,748] 11,334 [10,216–12,246] 22,160 [20,533–23,458] 7,281 [6,918–7,677] 29,440 [27,591–30,984] 5,561 [4,829–6,166] 2,375 [1,996–2,844] 7,936 [7,126–8,737] 13,054 [11,845–14,181] 4,820 [4,303–5,287] 17,874 [16,426–19,107]
Southern sub-Saharan 3,862 [3,634–4,317] 1,802 [1,501–2,162] 5,664 [5,185–6,330] 11,956 [11,335–12,490] 4,117 [3,818–4,503] 16,073 [15,403–16,759] 2,619 [2,394–2,964] 1,463 [1,178–1,830] 4,082 [3,661–4,598] 5,869 [5,460–6,291] 2,571 [2,336–2,885] 8,440 [7,944–9,008]
Africa 1,881 [1,774–1,996] 638 [591–684] 2,519 [2,402–2,642] 3,008 [2,754–3,289] 1,018 [916–1,127] 4,026 [3,755–4,333] 617 [579–657] 267 [248–287] 884 [845–927] 1,050 [937–1,170] 432 [380–495] 1,482 [1,361–1,618]
Western sub-Saharan 845 [803–892] 342 [314–376] 1,186 [1,131–1,253] 1,742 [1,643–1,845] 718 [664–775] 2,460 [2,346–2,576] 477 [446–513] 203 [183–230] 681 [638–732] 833 [758–908] 365 [325–410] 1,198 [1,117–1,285]
Africa 9,479 [9,189–9,769] 2,796 [2,688–2,906] 12,276 [11,983–12,579] 17,011 [16,318–17,768] 5,495 [5,135–5,878] 22,506 [21,692–23,381] 4,709 [4,517–4,881] 1,391 [1,334–1,452] 6,100 [5,898–6,277] 7,202 [6,774–7,709] 2,295 [2,114–2,488] 9,496 [9,033–10,048]
East Asia 17,461 [14,748–19,251] 4,904 [4,373–5,519] 22,365 [19,368–24,346] 20,295 [18,847–21,796] 5,549 [5,091–6,053] 25,844 [24,301–27,409] 7,882 [6,603–8,865] 2,063 [1,794–2,366] 9,945 [8,562–11,004] 8,885 [6,996–10,985] 2,285 [1,680–3,046] 11,169 [9,211–13,423]

Data in the parentheses indicates 95% uncertainty interval (95% UI). SDI, Sociodemographic index (a summary indicator of income per capita, educational attainment, and fertility).

Trends in bladder cancer-related deaths in the period from 1990 to 2016

Globally, there were 186,199 (95% UI, 180,453–191,686) deaths from bladder cancer in 2016, and the number of deaths was 137,883 (95% UI, 133,054–142,437) in males and 48,315 (95% UI, 46,028–50,487) in females. Between 1990 and 2016, deaths from bladder cancer rose 1.6-fold [113,414 (95% UI, 110,361–117,066) to 186,199 (95% UI, 180,453–191,686)]. In terms of SDI countries, the highest burden of bladder cancer deaths for both men and women occurred in high SDI countries (75,336; 95% UI, 72,679–77,841), followed by middle SDI countries (41,248; 95% UI, 38,787–42,863), high-middle SDI countries (38,889; 95% UI, 36,379–41,379), low-middle SDI countries (22,311; 95% UI, 20,831–23,545), and low SDI countries (8,320; 95% UI, 7,757–8,853). However, there was a decrease (18.65%) in bladder cancer deaths observed across all SDI countries from 1990 to 2016, especially in high-middle SDI countries. Among the regions, Oceania experienced the largest increase in bladder cancer-related deaths from 1990 to 2016, with a rise of 14.92% [from 29 (95% UI, 24–38) in 1990 to 78 (95% UI, 64–103) in 2016]. In 2016, bladder cancer mortality was much higher in men compared to women, with the number of death cases standing at 137,883 and 48,315, respectively (Table 1).

Trends in the age-standardized incidence rate (ASIR) of bladder cancer in the period from 1990 to 2016

Globally, between 1990 and 2016, changes in the ASIR for bladder cancer decreased by 5.91% from 7.11 (95% UI, 6.93–7.27) in 1990 to 6.69 (95% UI, 6.52–6.85) in 2016. In 2016, the highest ASIR was in high SDI countries (11.92; 95% UI, 11.53–12.28). However, the ASIR of bladder cancer in both sexes decreased in high SDI, high-middle SDI, and low SDI countries while it increased in middle SDI and low-middle SDI countries from 1990 to 2016. Between 1990 and 2016, ASIRs of bladder cancers remained highest in Western Europe, where the ASIR decreased by 7.97% from 15.93 (95% UI, 15.57–16.30) to 14.66 (95% UI, 13.93–15.24), followed by Central Europe, where it rose from 9.23 (95% UI, 9.03–9.45) to 12.05 (95% UI, 11.62–12.51). Globally, the age-standard bladder cancer incidence rate (per 100,000 people) in 2016 among men [11.54 (11.21–11.81)] was 4 times higher than among women [2.86 (2.75–2.98)] (Table 2, Figures 1,2).

Table 2. Global and regional age-standardized bladder cancer incidence and death rates with 95% uncertainty interval and percent change by geography, gender, and SDI between 1990 and 2016.

Location Sex Age-standardized incidence rates per 100,000 Age-standardized death rates per 100,000
1990 2016 Change (%) 1990 2016 Change (%)
Global Both 7.11 (6.93–7.27) 6.69 (6.52–6.85) −5.91 3.58 (3.49–3.68) 2.94 (2.85–3.03) −17.88
Male 12.47 (12.713–12.79) 11.54 (11.21–11.81) −7.46 6.29 (6.09–6.50) 5.10 (4.93–5.27) −18.92
Female 3.18 (3.10–3.27) 2.86 (2.75–2.98) −10.06 1.74 (1.68–1.81) 1.35 (1.28–1.41) −22.41
High SDI Both 12.68 (12.49–12.87) 11.92 (11.53–12.28) −6 4.65 (4.58–4.72) 3.84 (3.71–3.96) −17.42
Male 23.45 (23.01–23.91) 20.76 (19.91–21.42) −11.47 8.74 (8.58–8.91) 6.89 (6.60–7.16) −21.17
Female 5.25 (5.15–5.35) 5.07 (4.84–5.30) −1.52 2.14 (2.10–2.19) 1.70 (1.62–1.79) −20.56
High‐middle SDI Both 7.65 (7.16–7.99) 7.62 (7.36–7.88) −0.39 3.86 (3.61–4.04) 3.14 (2.94–3.33) −18.65
Male 14.94 (13.91–15.68) 14.18 (13.68–14.67) −5.09 7.84 (7.29–8.28) 6.05 (5.63–6.47) −22.83
Female 2.79 (2.63–2.95) 2.75 (2.58–2.90) −1.43 1.44 (1.36–1.51) 1.15 (1.04–1.28) −20.14
Middle SDI Both 3.44 (3.33–3.61) 4.10 (3.86–4.21) 19.19 2.63 (2.53–2.77) 2.17 (2.05–2.25) −17.49
Male 5.46 (5.29–5.78) 6.78 (6.40–6.97) 24.18 4.24 (4.06–4.53) 3.62 (3.41–3.77) −14.62
Female 1.74 (1.70–1.82) 1.76 (1.64–1.85) 11.49 1.35 (1.27–1.42) 0.98 (0.91–1.05) −27.41
Low‐middle SDI Both 2.48 (2.22–2.68) 2.75 (2.60–2.88) 10.89 2.01 (1.82–2.21) 1.94 (2.05–1.80) −3.48
Male 3.60 (3.19–3.88) 4.29 (4.00–4.56) 19.17 2.84 (2.45–3.14) 2.97 (2.71–3.21) 4.58
Female 1.48 (1.33–1.72) 1.39 (1.34–1.44) −6.08 1.28 (1.07–1.53) 1.06 (0.97–1.15) −17.19
Low SDI Both 3.00 (2.79–3.35) 2.88 (2.74–3.01) −4 3.23 (2.97–3.63) 3.21 (2.99–3.42) −0.62
Male 4.04 (3.80–4.62) 3.89 (3.62–4.13) −3.71 4.32 (3.89–5.02) 4.33 (3.93–4.70) 0.23
Female 2.09 (1.82–2.44) 1.99 (1.87–2.13) −4.78 2.29 (2.70–1.97) 2.23 (1.99–2.44) −2.62
High‐income Asia Pacific Both 7.12 (6.96–7.27) 7.33 (6.85–7.74) 2.95 2.59 (2.53–2.66) 2.22 (2.06–2.39) −14.29
Male 12.84 (12.49–13.21) 13.14 (12.18–13.9) 2.34 4.57 (4.42–4.73) 4.09 (3.75–4.44) −10.5
Female 3.18 (3.10–3.27) 3.00 (2.81–3.23) −5.66 1.36 (1.32–1.40) 1.01 (0.93–1.11) −25.74
Western Europe Both 15.93 (15.57–16.30) 14.66 (13.93–15.24) −7.97 5.93 (5.81–6.06) 4.77 (4.54–4.98) −19.56
Male 30.58 (29.75–31.43) 26.32 (24.83–27.48) −13.93 11.54 (11.25–11.85) 8.81 (8.30–9.28) −23.66
Female 5.86 (5.70–6.01) 5.53 (5.18–5.90) −5.63 2.53 (2.45–2.60) 1.92 (1.79–2.05) −24.11
Andean Latin America Both 2.41 (2.26–2.60) 2.27 (2.17–2.38) −5.81 1.87 (1.73–2.04) 1.49 (1.33–1.66) −20.32
Male 3.48 (3.28–3.74) 3.20 (2.99–3.43) −8.05 2.74 (2.51–3.00) 2.15 (1.86–2.47) −21.53
Female 1.53 (1.36–1.71) 1.52 (1.41–1.63) −0.65 1.17 (1.02–1.35) 0.98 (0.82–1.15) −16.24
Central Latin America Both 2.48 (2.41–2.53) 3.01 (2.93–3.09) 21.37 1.73 (1.68–1.78) 1.55 (1.48–1.62) −10.4
Male 3.64 (3.53–3.75) 4.34 (4.21–4.48) 19.23 2.56 (2.47–2.65) 2.28 (2.16–2.41) −10.94
Female 1.54 (1.50–1.60) 1.93 (1.81–2.00) 25.32 1.09 (1.04–1.13) 0.98 (0.91–1.04) −10.09
Southern Latin America Both 7.31 (6.96–7.67) 7.32 (6.90–7.76) 0.14 4.38 (4.14–4.63) 3.35 (3.05–3.69) −23.52
Male 13.57 (12.8–14.36) 12.86 (11.95–13.80) −5.23 8.21 (7.64–8.78) 6.07 (5.39–6.79) −26.07
Female 2.67 (2.49–2.85) 3.37 (3.08–3.67) 26.22 1.71 (1.57–1.85) 1.6 (1.40–1.84) −6.43
Tropical Latin America Both 4.34 (4.21–4.46) 5.04 (4.87–5.22) 16.13 3.08 (2.97–3.19) 2.74 (2.60–2.88) −11.04
Male 7.47 (7.21–7.72) 8.21 (7.82–8.57) 9.91 5.44 (5.18–5.70) 4.66 (4.35–4.94) −14.34
Female 2.13 (2.04–2.22) 2.80 (2.64–2.96) 31.46 1.51 (1.43–1.59) 1.46 (1.36–1.58) −3.31
North Africa and Middle East Both 6.03 (5.55–6.58) 7.85 (7.31–8.35) 30.18 4.42 (3.95–4.89) 4.09 (3.78–4.40) −7.47
Male 10.27 (9.38–11.25) 13.39 (12.44–14.31) 30.38 7.64 (6.78–8.48) 7.10 (6.49–7.73) −7.07
Female 2.32 (2.05–2.58) 2.81 (2.60–3.07) 21.12 1.71 (1.48–1.96) 1.49 (1.36–1.64) −12.87
High-income North America Both 11.90 (11.66–12.15) 11.67 (11.34–11.97) −1.93 3.95 (3.86–4.04) 3.73 (3.61–3.86) −5.57
Male 20.84 (20.37–21.32) 19.48 (18.85–20.11) −6.53 7.12 (6.94–7.30) 6.39 (6.13–6.65) −10.25
Female 5.60 (5.43–5.77) 5.41 (5.18–5.65) −3.39 1.98 (1.92–2.04) 1.80 (1.71–1.89) −9.09
Oceania Both 1.81 (1.58–2.30) 2.73 (2.44–3.30) 50.83 1.81 (1.59–2.43) 2.08 (1.81–2.71) 14.92
Male 2.43 (2.20–3.15) 3.79 (3.46–4.59) 55.97 1.03 (0.79–1.40) 1.19 (0.91–1.60) 15.53
Female 1.27 (0.98–1.66) 1.85 (1.49–2.35) 45.67 0.28 (0.23–0.33) 0.23 (0.19–0.28) −17.86
Central sub-Saharan Africa Both 3.44 (3.12–3.88) 3.12 (2.85–3.37) −9.3 3.44 (2.94–3.94) 3.29 (2.93–3.69) −4.36
Male 4.97 (4.44–5.87) 4.46 (3.92–4.97) −10.26 4.98 (3.95–6.05) 4.67 (3.97–5.49) −6.22
Female 2.35 (2.05–2.75) 2.08 (1.89–2.30) −11.49 2.36 (2.02–2.82) 2.23 (1.93–2.54) −5.51
Eastern sub-Saharan Africa Both 2.90 (2.70–3.10) 2.94 (2.58–3.23) 1.38 3.25 (2.97–3.59) 3.29 (2.84–3.60) 1.23
Male 3.61 (3.34–3.93) 3.72 (3.30–4.06) 3.05 4.02 (3.60–4.48) 4.19 (3.62–4.66) 4.23
Female 2.30 (2.00–2.65) 2.31 (1.97–2.71) 0.43 2.61 (2.17–3.12) 2.56 (2.10–3.02) −1.92
Central Asia Both 4.58 (3.90–5.02) 4.69 (4.41–4.94) 2.4 2.50 (2.14–2.77) 2.24 (2.07–2.43) −10.4
Male 9.26 (7.84–10.22) 9.14 (8.53–9.65) −1.3 5.20 (4.42–5.82) 4.52 (4.11–4.93) −13.08
Female 1.59 (1.39–1.83) 1.50 (1.39–1.61) −5.66 0.91 (0.79–1.07) 0.72 (0.65–0.80) −20.88
Southern sub-Saharan Africa Both 5.58 (4.86–6.13) 5.85 (5.38–6.27) 4.84 3.60 (2.88–4.15) 3.5 (3.18–3.83) −2.78
Male 8.01 (6.75–9.10) 9.27 (8.34–10.13) 15.73 5.27 (4.04–6.32) 5.85 (5.18–6.48) 11.01
Female 3.86 (3.46–4.16) 3.67 (3.45–3.91) −4.92 2.47 (2.06–2.82) 2.12 (1.86–2.4) −14.17
Western sub-Saharan Africa Both 2.41 (2.30–2.55) 2.23 (2.13–2.32) −7.47 2.77 (2.54–3.02) 2.53 (2.33–2.79) −8.66
Male 3.57 (3.39–3.80) 3.28 (3.14–3.40) −8.12 4.05 (3.63–4.50) 3.75 (3.41–4.17) −7.41
Female 1.43 (1.32–1.53) 1.31 (1.20–1.44) −8.39 1.70 (1.52–1.92) 1.5 (1.31–1.73) −11.76
East Asia Both 3.65 (3.52–3.85) 4.20 (3.95–4.38) 15.07 2.72 (2.59–2.85) 1.96 (1.85–2.05) −27.94
Male 5.91 (5.69–6.27) 7.10 (6.70–7.36) 20.14 4.49 (4.28–4.79) 3.34 (3.15–3.49) −25.61
Female 1.84 (1.74–1.94) 1.63 (1.49–1.78) −11.41 1.40 (1.30–1.50) 0.82 (0.74–0.90) −41.43
South Asia Both 2.32 (2.08–2.50) 2.69 (2.52–2.83) 15.95 2.08 (1.87–2.33) 1.97 (1.86–2.11) −5.29
Male 3.35 (3.00–3.62) 4.18 (3.86–4.43) 24.78 3.10 (2.83–3.52) 3.20 (2.97–3.43) 3.23
Female 1.29 (1.16–1.49) 1.29 (1.24–1.36) 0 1.33 (1.09–1.64) 1.08 (0.98–1.20) −18.8
Southeast Asia Both 2.63 (2.42–2.93) 3.34 (3.21–3.48) 27 2.08 (1.87–2.33) 1.97 (1.86–2.11) −5.29
Male 4.07 (3.83–4.56) 5.59 (5.31–5.84) 37.35 3.10 (2.83–3.52) 3.20 (2.97–3.43) 3.23
Female 1.52 (1.29–1.80) 1.58 (1.47–1.72) 3.95 1.33 (1.09–1.64) 1.08 (0.98–1.20) −18.8
Australasia Both 11.72 (11.20–12.28) 9.44 (8.81–10.14) −19.45 4.15 (3.97–4.34) 3.24 (2.97–3.54) −21.93
Male 20.58 (19.50–21.78) 15.54 (14.23–16.95) −24.49 7.31 (6.88–7.76) 5.33 (4.78–5.92) −27.09
Female 5.27 (4.90–5.65) 4.35 (3.92–4.80) −17.46 2.13 (1.97–2.28) 1.64 (1.44–1.88) −23
Caribbean Both 5.08 (4.84–5.37) 5.61 (5.35–5.89) 10.43 3.00 (2.82–3.22) 2.74 (2.56–2.94) −8.67
Male 7.76 (7.37–8.19) 8.76 (8.26–9.27) 12.89 4.58 (4.29–4.90) 4.32 (3.93–4.71) −5.68
Female 2.75 (2.53–3.01) 3.00 (2.77–3.25) 9.09 1.67 (1.50–1.88) 1.50 (1.33–1.69) −10.18
Central Europe Both 9.23 (9.03–9.45) 12.05 (11.62–12.51) 30.55 4.70 (4.55–4.84) 4.89 (4.66–5.17) 6.82
Male 17.08 (16.59–17.55) 21.60 (20.72–22.52) 26.46 9.05 (8.70–9.36) 9.37 (8.81–10.01) 6.94
Female 3.68 (3.55–3.81) 5.16 (4.82–5.51) 40.22 1.83 (1.76–1.91) 1.94 (1.79–2.1) 9.95
Eastern Europe Both 8.84 (7.70–9.60) 8.31 (7.84–8.80) −6 4.02 (3.49–4.42) 3.53 (2.90–4.25) −12.19
Male 20.46 (17.59–22.39) 18.04 (16.84–19.34) −11.83 10.34 (8.86–11.50) 8.37 (6.68–10.22) −19.05
Female 3.06 (2.73–3.45) 2.85 (2.62–3.09) −6.86 1.26 (1.09–1.43) 1.08 (0.79–1.44) −14.29

Data in the parentheses indicates 95% uncertainty interval (95% UI). SDI, Sociodemographic index (a summary indicator of income per capita, educational attainment, and fertility).

Figure 1.

Figure 1

Global and regional bladder cancer ASIR by geography and gender, 1990 and 2016. ASIR, age-standardized incidence rate; ATG, Antigua and Barbuda; VCT, Saint Vincent and the Grenadines; BRB, Barbados; COM, Comoros; MHL, Marshall Islands; KIR, Kiribati; MLT, Malta; DMA, Dominica; GRD, Grenada; MDV, Maldives; MUS, Mauritius; SLB, Solomon Islands; FSM, Federated States of Micronesia; VUT, Vanuatu; WSM, Samoa. SGP, Singapore; LCA, Saint Lucia; TTO, Trinidad and Tobago; TLS, Timor-Leste; SYC, Seychelles; FJI, Fiji; TON, Tonga.

Figure 2.

Figure 2

Global and regional average annual percent change in age-standardized incidence and death rates for bladder cancer by geography and gender, 1990–2016. (A) Average annual percent change in age-standardized incidence rates for bladder cancer by geography and gender, 1990–2016; (B) average annual percent change in age-standardized death rates for bladder cancer by geography and gender, 1990–2016. ATG, Antigua and Barbuda; VCT, Saint Vincent and the Grenadines; BRB, Barbados; COM, Comoros; MHL, Marshall Islands; KIR, Kiribati; MLT, Malta; DMA, Dominica; GRD, Grenada; MDV, Maldives; MUS, Mauritius; SLB, Solomon Islands; FSM, Federated States of Micronesia; VUT, Vanuatu; WSM, Samoa. SGP, Singapore; LCA, Saint Lucia; TTO, Trinidad and Tobago; TLS, Timor-Leste; SYC, Seychelles; FJI, Fiji; TON, Tonga.

Trends in the age-standardized death rate (ASDR) of bladder cancer in the period from 1990 to 2016

Globally, the ASDR of bladder cancer decreased from 3.58 (95% UI, 3.49–3.68) in 1990 to 2.94 (95% UI, 2.85–3.03) in 2016. Between 1990 and 2016, changes in ASDRs was highest among men in low-middle SDI countries, where the ASDRs increased by 4.58% from 2.84 (95% UI, 2.45–3.14) to 2.97 (95% UI, 2.71–3.21). Between 1990 and 2016, in terms of region, the highest changes in ASDR occurred in Oceania, followed by Central Europe. Simultaneously, ASDR decreased substantially in East Asia and Southern Latin America. Globally, the mortality rates of bladder cancer were higher among males than females, with male-to-female ratios of 3.7:1, which indicated that the age-standard bladder cancer death rate (per 100,000 people) among men [5.10 (4.93–5.27)] was approximately 3.7-fold higher than among women [1.35 (1.28–1.41)] (Table 2, Figures 2,3).

Figure 3.

Figure 3

Global and regional bladder cancer ASDR by geography and gender, 1990 and 2016. ASDR, age-standardized death rate; ATG indicates Antigua and Barbuda; VCT, Saint Vincent and the Grenadines; BRB, Barbados; COM, Comoros; MHL, Marshall Islands; KIR, Kiribati; MLT, Malta; DMA, Dominica; GRD, Grenada; MDV, Maldives; MUS, Mauritius; SLB, Solomon Islands; FSM, Federated States of Micronesia; VUT, Vanuatu; WSM, Samoa. SGP, Singapore; LCA, Saint Lucia; TTO, Trinidad and Tobago; TLS, Timor-Leste; SYC, Seychelles; FJI, Fiji; TON, Tonga.

Projections of bladder cancer incidence and mortality from 2017 to 2030

This study also forecast the trends in the incidence and mortality rates of bladder cancer from 2017 to 2030. Bladder cancer will occur most frequently in high SDI countries, followed by high-middle SDI countries. Bladder cancer incidence rates may increase substantially in middle SDI countries, while incidence rates for both men and women should remain relatively stable in other SDI countries. Deaths due to bladder cancer will continue to increase in low SDI countries, while in other SDI countries the decrease from 1990 will continue to 2030. Globally, the probability of developing bladder cancer for men between the ages of 30 and 70 is around 1.32%, compared to 0.32% for women. In other words, the estimated risk of suffering from bladder cancer is higher among men than women. Similar results can be seen in other age intervals and SDI countries (Table 3, Figure 4).

Table 3. Probability of developing bladder cancer within selected age intervals, globally, and by SDI quintile, by sex, 2006–2016 in % (odds).

Location/ SDI quintile Birth to age 49 Age 50 to 59 Age 60 to 69 Age 70 to 79 Age 30 to 70 Birth to age 79
Male Female Male Female Male Female Male Female Male Female Male Female
Global 0.05 (1 in 1,961) 0.02 (1 in 5,319) 0.14 (1 in 740) 0.04 (1 in 2,679) 0.38 (1 in 266) 0.09 (1 in 1,169) 0.77 (1 in 130) 0.18 (1 in 561) 1.32 (1 in 76) 0.32 (1 in 315) 1.33 (1 in 75) 0.32 (1 in 313)
High- middle SDI 0.06 (1 in 1,588) 0.02 (1 in 4,868) 0.18 (1 in 542) 0.04 (1 in 2,558) 0.52 (1 in 193) 0.09 (1 in 1,135) 0.98 (1 in 103) 0.18 (1 in 568) 1.73 (1 in 58) 0.32 (1 in 311) 1.73 (1 in 58) 0.32 (1 in 309)
High SDI 0.08 (1 in 1,227) 0.04 (1 in 2,800) 0.27 (1 in 375) 0.07 (1 in 1,388) 0.71 (1 in 140) 0.16 (1 in 618) 1.39 (1 in 72) 0.32 (1 in 316) 2.43 (1 in 41) 0.58 (1 in 172) 2.44 (1 in 41) 0.58 (1 in 171)
Low-middle SDI 0.03 (1 in 3,478) 0.01 (1 in 8,843) 0.06 (1 in 1,621) 0.02 (1 in 4,529) 0.15 (1 in 646) 0.05 (1 in 2,066) 0.26 (1 in 377) 0.08 (1 in 1,206) 0.51 (1 in 197) 0.16 (1 in 611) 0.51 (1 in 196) 0.16 (1 in 608)
Low SDI 0.03 (1 in 3,864) 0.02 (1 in 6,406) 0.05 (1 in 2,020) 0.03 (1 in 3,135) 0.13 (1 in 787) 0.07 (1 in 1,453) 0.26 (1 in 385) 0.10 (1 in 964) 0.46 (1 in 217) 0.22 (1 in 457) 0.46 (1 in 217) 0.22 (1 in 455)
Middle SDI 0.05 (1 in 1,885) 0.02 (1 in 5,801) 0.10 (1 in 1,034) 0.03 (1 in 3,640) 0.24 (1 in 422) 0.05 (1 in 1,855) 0.43 (1 in 232) 0.11 (1 in 927) 0.81 (1 in 123) 0.20 (1 in 490) 0.82 (1 in 122) 0.21 (1 in 485)

Data in the parentheses indicates 95% uncertainty interval (95% UI). SDI, sociodemographic index (a summary indicator of income per capita, educational attainment, and fertility).

Figure 4.

Figure 4

Global and regional trends and predictions in age-standardized incidence and death rates for bladder cancer by SDI quintile, 1990–2030. (A) Trends and predictions in age-standardized incidence rates for bladder cancer by SDI quintile, 1990–2030; (B) trends and predictions in age-standardized death rates for bladder cancer by SDI quintile, 1990–2030. SDI, Sociodemographic index (a summary indicator of income per capita, educational attainment, and fertility).

Discussion

The estimates presented in this study reveal remarkable differences in trends in the incidence and death rates of bladder cancer from 1990 to 2016. New bladder cancer diagnoses and related deaths increased while the ASIR and ASDR decreased over the same time period. At a global level, between 1990 and 2016, the decreasing incidence rate of bladder cancer was particularly noticeable. Cancer outcomes depend on health care expenditures as well as adequate diagnosis and treatment services (11). Trends in the incidence and death rates of bladder cancer were evaluated for both sexes, and these rates were observed to be greater in males than females across all SDI countries and most regions. A large proportion of the increase in bladder cancer incidence can be attributed to improving life expectancy and population growth (16). Tobacco smoking is the dominant risk factor for bladder cancer and is associated with 50–65% of male cases and 20–30% of female cases (17-19). Furthermore, genetic predisposition, occupational exposure to aromatic amines, polycyclic aromatic hydrocarbons, chlorinated hydrocarbons, cyclophosphamide, pioglitazone, exposure to ionising radiation, and chlorination of drinking water and subsequent levels of trihalomethanes have all been suggested as contributing to the development of bladder cancer (20). Clinically, early symptoms of bladder cancer include bloody urine or pain during urination. In its early stages, the disease can be treated cystoscopically plus immunotherapy with Bacillus Calmette-Guérin (BCG) (21); however, up to 70% of tumors recur (22,23). Early detection of bladder cancer and a high recurrence rate of bladder cancer may be two of the reasons for the sharp increase in the incidence and deaths of bladder cancer seen in recent years.

For chronic diseases such as bladder cancer, it is especially important to develop appropriate and reasonable strategies for prevention and control. Epidemiology references are absolutely imperative in bladder cancer prevention, screening, and treatment. In our study, data of bladder cancer were analyzed by age group, gender, geographical region, and SDI. We found that there are differences in the incidence and mortality of bladder cancer regardless of age group, gender, region, or SDI. Additionally, we also forecast the trends in the incidence and mortality rates of bladder cancer from 2017 to 2030. What we did has considerable significance in terms of the proposal of bladder cancer prevention and control strategies. However, although we extracted the data accurately, there is likely a small amount of bias in the prediction results. However, future trends in bladder cancer are worthy of attention.

Conclusions

Globally, between 1990 and 2016, the incidence and death cases of bladder cancer increased substantially, while the ASIR and ASDR of bladder cancer decreased. The incidence and mortality rates of bladder cancer will continue to increase among some SDI countries and regions in the next 15 years. Policy makers in different regions should devise improved strategies for bladder cancer prevention and control.

Supplementary

The article’s supplementary files as

tau-09-02-153-coif.pdf (281.3KB, pdf)
DOI: 10.21037/tau.2020.02.24

Acknowledgments

We thank the Global Burden of Disease Study for collection of the GBD data.

Funding: This study was funded by the National Natural Science Foundation of China (No. 91746205), IBM Global University Programs (2018 IBM Shared University Research Award), Natural Science Foundation of Tianjin (No. 17JCYBJC26000), Tianjin Technical Expert Project and Hospital Innovation & Management Research Project of Tianjin Medical University (No. 2019YG08).

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Footnotes

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tau.2020.02.24). The authors have no conflicts of interest to declare.

References

  • 1.Fitzmaurice C, Akinyemiju TF, Al Lami FH, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol 2018;4:1553-68. 10.1001/jamaoncol.2018.2706 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:7-30. 10.3322/caac.21442 [DOI] [PubMed] [Google Scholar]
  • 3.Heney NM, Ahmed S, Flanagan MJ, et al. Superficial bladder cancer: progression and recurrence. J Urol 1983;130:1083. 10.1016/S0022-5347(17)51695-X [DOI] [PubMed] [Google Scholar]
  • 4.Chavan S, Bray F, Lortet-Tieulent J, et al. International variations in bladder cancer incidence and mortality. Eur Urol 2014;66:59-73. 10.1016/j.eururo.2013.10.001 [DOI] [PubMed] [Google Scholar]
  • 5.Antoni S, Ferlay J, Soerjomataram I, et al. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 2017;71:96-108. 10.1016/j.eururo.2016.06.010 [DOI] [PubMed] [Google Scholar]
  • 6.Fitzmaurice C, Allen C, Barber RM, et al. Global Burden of Disease Cancer Collaboration . Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol 2017;3:524-48. 10.1001/jamaoncol.2016.5688 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1151-210. 10.1016/S0140-6736(17)32152-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1260-344. 10.1016/S0140-6736(17)32130-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Global Burden of Disease Cancer Collaboration , Fitzmaurice C, Dicker D, et al. The Global Burden of Cancer 2013. JAMA Oncol 2015;1:505-27. 10.1001/jamaoncol.2015.0735 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Forouzanfar MH, Alexander L, Anderson HR, et al. Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386:2287-323. 10.1016/S0140-6736(15)00128-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117-71. 10.1016/S0140-6736(14)61682-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386:743-800. 10.1016/S0140-6736(15)60692-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Stevens GA, Alkema L, Black RE, et al. GATHER Working Group . Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. PLoS Med 2016;13:e1002056. 10.1371/journal.pmed.1002056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1211-59. 10.1016/S0140-6736(17)32154-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1345-422. 10.1016/S0140-6736(17)32366-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008;9:730-56. 10.1016/S1470-2045(08)70179-7 [DOI] [PubMed] [Google Scholar]
  • 17.GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1084-150. 10.1016/S0140-6736(17)31833-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet 2009;374:239-49. 10.1016/S0140-6736(09)60491-8 [DOI] [PubMed] [Google Scholar]
  • 19.Freedman ND, Silverman DT, Hollenbeck AR, et al. Association between smoking and risk of bladder cancer among men and women. JAMA 2011;306:737-45. 10.1001/jama.2011.1142 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013;63:234-41. 10.1016/j.eururo.2012.07.033 [DOI] [PubMed] [Google Scholar]
  • 21.Malmström PU, Sylvester RJ, Crawford DE, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guerin for non-muscle-invasive bladder cancer. Eur Urol 2009;56:247-56. 10.1016/j.eururo.2009.04.038 [DOI] [PubMed] [Google Scholar]
  • 22.Stewart BW, Wild CP. World Cancer Report 2014. World Health Organization. 2014:Chapter 1.1.ISBN9283204298. [Google Scholar]
  • 23.Yoshino H, Enokida H, Chiyomaru T, et al. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer. Biochem Biophys Res Commun 2012;417:588-93. 10.1016/j.bbrc.2011.12.011 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

The article’s supplementary files as

tau-09-02-153-coif.pdf (281.3KB, pdf)
DOI: 10.21037/tau.2020.02.24

Articles from Translational Andrology and Urology are provided here courtesy of AME Publications

RESOURCES